Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,17206,307,3.81 [1.92-7.54],0.0001234082375788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,16725,292,0.91 [0.73-1.14],0.4206987409285377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,19668,335,1.03 [0.86-1.24],0.7127092874236778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,16602,297,1.19 [0.85-1.67],0.311754189397318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,19532,336,0.97 [0.81-1.16],0.709358790353713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,19668,335,1.05 [0.91-1.22],0.5070368091397417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,17214,308,1.01 [0.93-1.09],0.8337785670562841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,16602,297,1.07 [0.90-1.27],0.4734996331187756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19301,331,1.39 [1.24-1.55],1.131165166766276e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",16895,301,1.09 [0.93-1.28],0.2792733538949893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",17199,308,1.03 [0.91-1.17],0.5958769434882012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,19564,334,1.23 [0.86-1.78],0.2617889032145335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,17214,308,2.82 [1.88-4.24],5.120033171797598e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,19402,328,1.52 [1.29-1.79],3.940651219674426e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,16814,295,1.42 [1.04-1.95],0.0285238079674712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,17141,308,1.11 [1.01-1.23],0.0347567925286644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,19764,335,1.17 [0.96-1.43],0.1103872958444254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,16677,295,0.67 [0.51-0.89],0.0051873736737292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,19854,339,1.76 [1.32-2.36],0.0001333262638592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,19916,343,1.20 [1.02-1.41],0.0259881115904162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,17140,308,1.11 [0.83-1.49],0.4683134986845652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,16677,295,0.83 [0.73-0.94],0.0039144107139033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,16602,297,1.30 [0.94-1.78],0.1084063267661436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",19402,328,1.29 [1.06-1.58],0.0125388007349687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,16602,297,1.04 [0.87-1.25],0.6559405414761937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,19413,332,0.80 [0.56-1.15],0.2275713516352164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,19556,336,2.17 [1.54-3.06],8.605383283370498e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,19764,335,1.26 [1.08-1.46],0.0026201489084003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,16602,297,1.32 [1.09-1.61],0.0046052384525607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,16758,295,1.07 [0.90-1.28],0.4406728375092943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,20006,342,1.45 [1.13-1.87],0.0033614639341936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,19667,335,2.00 [1.62-2.46],5.94705794610907e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,16677,295,2.35 [1.79-3.07],5.0283103508214e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,19402,328,1.96 [1.42-2.71],4.567372679596623e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,19592,336,0.49 [0.37-0.64],2.4102126373189295e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20006,342,0.69 [0.53-0.89],0.0038931566140908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,19917,341,1.75 [1.29-2.39],0.0003539367507623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17141,308,2.26 [1.63-3.12],8.818045561701964e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,16677,295,1.76 [1.29-2.40],0.0003735810563926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,20015,341,0.49 [0.33-0.74],0.0005698138986228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,19668,335,1.45 [1.14-1.85],0.0026342342741036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,19402,328,1.26 [0.94-1.68],0.1233239303843773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,16677,295,1.43 [1.06-1.93],0.0204243563293496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,19829,337,0.81 [0.65-1.01],0.0627246031648478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,17201,308,3.31 [2.55-4.29],2.615829502385287e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,16725,292,1.66 [1.04-2.65],0.0351438407635839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,17199,308,1.11 [0.84-1.47],0.4507665949875489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,19301,331,0.97 [0.72-1.32],0.8546677756112662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,16814,295,0.91 [0.77-1.08],0.2810507417618709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,19556,336,1.06 [0.79-1.43],0.7014460271431912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,16814,295,2.30 [1.80-2.93],1.6483492533067373e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,17141,308,1.39 [1.14-1.70],0.0013253306707852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,19840,341,1.18 [0.84-1.66],0.3425423282318496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,19918,340,1.10 [0.80-1.50],0.5643168215611827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,17199,308,1.35 [0.89-2.03],0.1565180421154686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,19668,335,1.37 [1.24-1.52],2.163835149692111e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,19764,335,0.82 [0.57-1.18],0.2804553944598652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,16636,304,1.13 [0.97-1.30],0.1153028615735591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,16814,295,0.91 [0.78-1.06],0.2064874901033125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,19402,328,0.92 [0.82-1.04],0.2002439305723061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,17206,307,1.49 [1.27-1.75],1.4431905698563929e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,19939,343,3.84 [2.65-5.55],9.090145844150761e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,16602,297,1.09 [0.93-1.29],0.2945795604286741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,16814,295,0.87 [0.75-1.01],0.0646651241380708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,17206,307,0.73 [0.42-1.28],0.2724835427730778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,19518,334,1.16 [0.99-1.35],0.0693158430281078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,16636,304,0.99 [0.87-1.13],0.8609950275049968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,19716,337,0.92 [0.72-1.17],0.4826837432532008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,19188,325,1.16 [1.04-1.29],0.0059177438309891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,19271,329,0.95 [0.80-1.14],0.5991883349073557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,19840,341,1.66 [1.30-2.12],5.593062897389167e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,20006,342,0.95 [0.79-1.15],0.5919140473723392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,17214,308,1.11 [0.68-1.81],0.6842440040302253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,19764,335,1.18 [1.04-1.34],0.009862595725459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,19764,335,1.10 [0.95-1.28],0.1860897555335344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,16725,292,1.09 [0.78-1.54],0.6077249383421759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,16725,292,1.22 [0.86-1.74],0.2671170579328221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,17140,308,1.07 [0.90-1.27],0.4266677043231485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,17214,308,1.06 [0.69-1.62],0.7984074195124673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,19741,338,1.11 [0.98-1.26],0.0929288582359685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",16735,300,1.07 [0.92-1.23],0.3726982025783177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,19301,331,1.28 [1.05-1.55],0.0125265780064371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,16725,292,0.93 [0.74-1.16],0.5078028986168048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",19641,335,1.21 [1.11-1.33],3.197835839933669e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,19764,335,1.16 [0.99-1.35],0.0715970338741936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",17155,308,1.11 [0.99-1.24],0.0620939717757721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,16814,295,1.04 [0.61-1.80],0.8798052640179692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,19301,331,1.03 [0.89-1.18],0.7128182101508984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,16735,300,1.33 [1.13-1.56],0.0006100780001498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,19402,328,1.17 [0.98-1.39],0.0753077492341483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,16677,295,1.11 [0.94-1.31],0.2156146851634711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,19332,331,1.06 [0.91-1.24],0.4700521233750789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,17167,307,0.99 [0.91-1.08],0.837779526212479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,19208,331,0.92 [0.77-1.11],0.387201852635158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,20015,341,2.32 [1.46-3.66],0.0003311861144001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,19776,339,1.24 [1.05-1.48],0.0138590721354897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",17140,308,1.12 [0.90-1.40],0.3033764944514129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",19716,332,1.28 [1.13-1.45],7.244473770534162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17167,307,1.53 [1.23-1.90],0.0001160369987713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,16895,301,0.99 [0.75-1.32],0.9707982626988146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,16677,295,1.01 [0.91-1.11],0.8943295364322177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",19668,335,1.25 [1.16-1.35],5.360718622324482e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,19413,332,0.84 [0.55-1.27],0.4029992787659457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,19911,341,1.57 [0.98-2.52],0.0627073858246353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,17201,308,1.02 [0.65-1.58],0.9434718552944952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,19332,331,1.07 [0.91-1.25],0.3931137368595609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,16735,300,1.08 [0.87-1.35],0.4627770579009337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,19668,335,1.69 [1.10-2.58],0.0165883036676894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,19413,332,0.92 [0.75-1.14],0.4626934363475047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,16814,295,1.03 [0.77-1.37],0.8634092130587514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,17065,307,1.08 [0.84-1.38],0.5340413268944444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,17155,308,1.04 [0.89-1.22],0.61830002116817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,16159,283,0.86 [0.68-1.10],0.2266257717532427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,19045,326,0.71 [0.58-0.88],0.0017606032484382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,18449,320,0.67 [0.54-0.83],0.0002557437685481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,19733,336,1.47 [1.10-1.96],0.0098563621811808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,19695,337,1.02 [0.91-1.15],0.7507864196109573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,19939,343,3.02 [2.41-3.77],5.0698333776352e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,19459,324,2.56 [1.82-3.61],7.805310115670452e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,19770,340,1.36 [1.07-1.74],0.0117272823734445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,19802,337,1.68 [1.26-2.25],0.0004525499281058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,19811,340,1.99 [1.60-2.46],2.9208020371272144e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,19939,343,1.36 [1.05-1.75],0.0182981360611958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,16602,297,1.04 [0.88-1.22],0.6749683044611949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,16677,295,1.01 [0.87-1.17],0.8646273022856161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,16595,297,1.12 [0.91-1.38],0.2831845915832519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,19301,331,1.15 [0.98-1.35],0.0967975374476576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,16725,292,0.85 [0.60-1.20],0.3510090397105118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,19839,338,1.66 [1.17-2.38],0.004997797050426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,16732,294,0.99 [0.77-1.26],0.922010017389586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,19332,331,1.38 [1.24-1.54],4.334232476050843e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,19717,331,0.99 [0.85-1.16],0.9159867543658692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,16477,288,1.21 [1.04-1.41],0.0140487309471102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,19917,341,1.06 [0.92-1.22],0.4312485998323909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,19679,332,1.02 [0.89-1.18],0.7275770285250386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,19271,326,1.36 [0.97-1.91],0.0759733693753772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],19413,332,1.00 [0.83-1.20],0.9961769504586552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,19867,338,2.83 [2.04-3.93],5.497366473145606e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,17140,308,1.10 [0.96-1.27],0.1689633946077352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,16735,300,1.02 [0.81-1.29],0.8649789116836067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,17141,308,1.09 [0.95-1.27],0.2273954941849059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,17155,308,1.04 [0.83-1.32],0.7100398111209026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,19668,335,1.10 [0.89-1.36],0.3657119133600131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,17060,303,0.72 [0.51-1.02],0.0623843007464705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,19886,343,1.12 [0.95-1.33],0.1792654008353101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,19764,335,0.60 [0.49-0.73],6.682394829069546e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,17206,307,1.35 [0.93-1.96],0.1159767564754651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,17214,308,1.27 [1.02-1.59],0.0361241182525169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,17206,307,0.92 [0.67-1.27],0.6211780823476942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,17214,308,1.09 [0.65-1.83],0.7502621418667383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,16725,292,1.01 [0.77-1.32],0.9602989808573827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,17178,306,1.06 [0.80-1.40],0.6939155110778001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,16465,292,1.00 [0.75-1.33],0.9893504603022436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,17206,307,1.11 [0.96-1.28],0.1701203441198613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,17214,308,0.90 [0.61-1.32],0.5768984314465548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,19776,339,1.21 [0.93-1.57],0.1651050571498821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,17214,308,0.91 [0.74-1.12],0.3727446538411768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,19837,338,0.93 [0.67-1.30],0.6856288857690227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,19746,339,1.07 [0.93-1.25],0.3410871719893329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,16814,295,0.97 [0.88-1.08],0.618742026861475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,19560,336,1.05 [0.85-1.31],0.6379946779511045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,16895,301,0.96 [0.80-1.15],0.6893874524129296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,19668,335,2.75 [2.27-3.33],6.326671754291632e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,17141,308,0.99 [0.89-1.10],0.8649569649715922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,17167,307,1.06 [0.90-1.24],0.5175995736707375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,19642,338,0.89 [0.73-1.08],0.2320552526535806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",17140,308,0.90 [0.67-1.20],0.472846025202174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,19301,331,0.93 [0.75-1.16],0.5157221973677752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,19301,331,0.95 [0.80-1.12],0.5389296450707355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,16895,301,0.94 [0.68-1.31],0.7126063872266921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,16814,295,0.99 [0.86-1.14],0.9196375488941942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,16595,297,1.06 [0.91-1.23],0.4658759637388464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,17155,308,1.08 [0.95-1.22],0.2651374191476886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,17167,307,1.07 [0.94-1.20],0.3019455426276796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,19752,333,0.96 [0.87-1.06],0.4085822547415494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,16636,304,1.14 [0.98-1.33],0.0826525070196206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,16636,304,1.02 [0.75-1.38],0.8956890512522926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,19332,331,0.99 [0.78-1.27],0.960615920418428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,16602,297,1.22 [1.04-1.43],0.0160080613882298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,16602,297,0.95 [0.71-1.28],0.7415659691978258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,16636,304,1.13 [0.95-1.36],0.1778985855782585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,19413,332,0.91 [0.67-1.23],0.5470539545277122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,16602,297,0.97 [0.76-1.24],0.81105479870862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,19776,339,1.16 [0.93-1.44],0.1793480617788849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,19668,335,1.20 [1.01-1.43],0.0361407950883022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,19867,338,0.77 [0.58-1.01],0.0568388009324251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,16636,304,0.93 [0.77-1.14],0.4944004942868578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,19413,332,1.24 [1.03-1.50],0.0253289033559954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,17042,307,1.49 [1.20-1.85],0.0003719655534751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,19592,336,0.86 [0.73-1.02],0.0928976017929573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,19592,336,2.43 [1.81-3.25],2.9070502919065244e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,17214,308,2.01 [1.34-3.00],0.0006802730644455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,17199,308,1.80 [1.30-2.49],0.0003909279549792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,17167,307,0.99 [0.83-1.17],0.8697343401709248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,16725,292,0.97 [0.87-1.09],0.6485802810739851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,16602,297,0.80 [0.69-0.93],0.003502543329439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,19332,331,1.02 [0.88-1.18],0.7848637870434851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,16595,297,1.04 [0.73-1.49],0.8377643507567776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,17141,308,1.03 [0.90-1.17],0.7088946799162883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,19301,331,1.11 [0.94-1.32],0.2007610133789726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,19829,337,1.24 [1.07-1.43],0.0041601558952519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,16602,297,1.04 [0.83-1.31],0.735274370435016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,16602,297,1.06 [0.72-1.57],0.7495742247308271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,16602,297,1.10 [0.82-1.48],0.5166758306862853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,16595,297,1.15 [0.87-1.51],0.3203948241419689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,16602,297,1.09 [0.90-1.33],0.3860703400993753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",16602,297,0.85 [0.66-1.10],0.2138350804443909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",19840,341,1.06 [0.97-1.16],0.2064321352597584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",19332,331,1.00 [0.77-1.28],0.9707698503980788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,19301,331,1.14 [0.89-1.46],0.2945547161987857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,19668,335,0.90 [0.61-1.31],0.5781815469672542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,19305,331,1.09 [0.94-1.27],0.2717279171747392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,16725,292,1.00 [0.85-1.17],0.9890426616460744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,16602,297,0.97 [0.85-1.11],0.7071567408505526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,17141,308,1.56 [1.16-2.10],0.0032590253756174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",17206,307,0.85 [0.43-1.71],0.6564107361536907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,19332,331,0.94 [0.81-1.08],0.3838524292770051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,16636,304,1.02 [0.92-1.14],0.6987173065903745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,17167,307,1.05 [0.82-1.33],0.7135480489076536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,17155,308,1.04 [0.86-1.25],0.6699354594549831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,19752,333,0.98 [0.88-1.09],0.65318609110188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,19867,338,0.99 [0.69-1.42],0.966989599040756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,17167,307,1.09 [0.89-1.34],0.4053152299090723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,19200,325,1.12 [1.00-1.27],0.0577324852810226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,17206,307,1.71 [1.34-2.17],1.1912836723094514e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,16602,297,1.41 [0.79-2.49],0.242759306225595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",16725,292,1.69 [1.23-2.32],0.0011846515110801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",19840,341,2.15 [1.53-3.01],9.447659990024412e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",19776,339,0.92 [0.61-1.39],0.6920593929059005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,16677,295,1.35 [0.95-1.93],0.0970690909459587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,19752,333,1.09 [0.95-1.25],0.2110591896098046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,19556,336,0.72 [0.57-0.91],0.0060183969349283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,16677,295,1.08 [0.86-1.36],0.4865350812499042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,19402,328,1.01 [0.77-1.33],0.9514538080722156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19301,331,1.27 [1.10-1.47],0.0010699519987944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,19301,331,1.36 [0.98-1.90],0.0667560689402804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,19752,333,0.96 [0.88-1.06],0.4651544672675957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,17155,308,1.14 [0.98-1.33],0.0845834672256858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,16735,300,1.13 [0.99-1.29],0.0638530356962547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,19300,328,1.10 [0.98-1.23],0.1001198133624412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,19776,339,2.34 [1.61-3.39],6.979856836187165e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,19592,336,0.29 [0.22-0.39],1.0521161502266717e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",17199,308,1.68 [1.24-2.27],0.0007926790399857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",16636,304,0.94 [0.75-1.17],0.5729593507221202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,16902,301,0.50 [0.34-0.73],0.0003947547029337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,17141,308,1.01 [0.82-1.26],0.9018218075935408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,17155,308,1.06 [0.94-1.18],0.3577726681992453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",19752,333,1.20 [0.94-1.54],0.1492806091025868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,16677,295,1.12 [0.94-1.35],0.2118301331126283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,16595,297,1.09 [0.93-1.29],0.2832964363582675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,17140,308,0.98 [0.75-1.28],0.8851779785343654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,19752,333,0.99 [0.89-1.11],0.8988143295586789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,17201,308,1.02 [0.89-1.17],0.7639854598403346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,16725,292,1.03 [0.85-1.25],0.7905262776304709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,16595,297,0.89 [0.67-1.18],0.4159764738518984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,17201,308,1.13 [0.99-1.29],0.0630383919480013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,19273,329,0.93 [0.85-1.02],0.1130074670838355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,16636,304,1.09 [0.92-1.28],0.3137796404580174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,16602,297,1.60 [0.99-2.59],0.0535915599825984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,19752,333,1.07 [0.92-1.23],0.3750694129752366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,19776,339,1.04 [0.93-1.16],0.4756008759436723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,19301,331,0.95 [0.81-1.12],0.5510491956583186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,20015,341,1.00 [0.73-1.36],0.997381310208558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,16677,295,0.91 [0.68-1.22],0.5146480139697811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,16636,304,0.97 [0.82-1.14],0.6989121334226117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,17155,308,1.10 [0.84-1.45],0.4796352713666164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,19776,339,1.12 [0.96-1.30],0.1482768864459354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,16814,295,1.98 [1.30-3.00],0.0013191408467384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,19556,336,1.08 [0.88-1.33],0.4673181297521114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,19370,327,1.30 [1.01-1.68],0.0381734730435198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,16814,295,2.86 [1.88-4.36],1.0370502255341188e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,17199,308,1.24 [0.90-1.73],0.1928657530595839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,16677,295,1.36 [1.05-1.74],0.0179041302826626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,19402,328,1.35 [0.88-2.07],0.1690569644231099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,16636,304,1.09 [0.90-1.32],0.3821903035508899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,16725,292,0.96 [0.77-1.20],0.7449972874043556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,16163,282,0.99 [0.89-1.10],0.8404785479383062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,19738,336,1.57 [1.34-1.83],1.3522939078042569e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,17169,308,1.05 [0.87-1.26],0.6404528504897463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,16976,304,0.96 [0.87-1.07],0.5051338351980514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,16895,301,1.22 [0.85-1.76],0.2860293319155337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,16636,304,1.10 [0.78-1.56],0.5933196079298483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,16602,297,0.78 [0.59-1.03],0.0757548002681611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,16602,297,1.12 [0.82-1.53],0.486298401920793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,19332,331,1.24 [0.99-1.55],0.0554463848019054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,16636,304,0.87 [0.64-1.18],0.3714044251046186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,17167,307,1.46 [1.10-1.94],0.0083981403319147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,19972,341,3.99 [2.58-6.17],5.018376937347292e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,16595,297,1.17 [0.85-1.61],0.3317330210326392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,19950,342,1.11 [0.88-1.38],0.3757308317075002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,19950,342,1.65 [1.43-1.90],9.672583193517927e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,19301,331,1.07 [0.93-1.23],0.3327217097957453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,17206,307,0.57 [0.33-0.97],0.039870743930793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,16595,297,1.04 [0.91-1.19],0.5337843527876585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,17105,308,0.70 [0.49-1.00],0.0524393936184848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,19840,341,1.88 [1.34-2.65],0.0002925851878068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,19752,333,1.59 [1.24-2.05],0.0002896002668558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,16595,297,0.93 [0.69-1.25],0.633028605732137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,19332,331,1.13 [0.98-1.30],0.0828576932410833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,16602,297,1.13 [0.82-1.56],0.4515638379723063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,19910,341,2.04 [1.35-3.08],0.0006734613705342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",17167,307,1.06 [0.90-1.24],0.502976909852678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,16677,295,1.19 [0.93-1.53],0.1732199451911075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,19867,338,1.84 [1.49-2.26],1.0971985712595052e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,16814,295,1.45 [1.05-2.00],0.0237171797153839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,17167,307,1.49 [1.11-2.01],0.0087311103669878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,16788,295,0.89 [0.70-1.12],0.3123301216984511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,17206,307,1.98 [1.25-3.13],0.0035943161221928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,17175,306,1.79 [1.00-3.20],0.0513896282067733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,17206,307,2.22 [1.35-3.66],0.0017086985239191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,19837,338,1.68 [1.04-2.72],0.0324586305993683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,19305,331,1.31 [1.04-1.66],0.023821372496301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,16735,300,1.07 [0.88-1.30],0.5138160076461196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,16358,289,1.42 [1.15-1.76],0.0010417893812936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,19829,337,0.80 [0.62-1.03],0.0864035795365245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,17206,307,2.64 [1.35-5.17],0.0047249239147223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,16796,302,4.36 [3.24-5.87],2.7110245276473724e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,17155,308,1.25 [0.79-1.96],0.3412871255603324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,17206,307,1.46 [1.00-2.13],0.0488728900164132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,17214,308,1.35 [1.11-1.65],0.0032702991752661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,17141,308,0.99 [0.86-1.15],0.8987400228533656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,19371,330,1.02 [0.86-1.22],0.8055116073521376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,19301,331,1.33 [0.99-1.80],0.0609324461846013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,19668,335,1.77 [1.36-2.32],2.666672671315016e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,19541,329,0.99 [0.90-1.09],0.870222290328958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,19939,343,0.46 [0.35-0.60],1.4771341135959252e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,19713,338,1.11 [0.96-1.28],0.1702556415553184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,19985,341,1.03 [0.88-1.21],0.7126101106810541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,20015,341,2.62 [1.78-3.87],1.2492005926668977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",19402,328,1.14 [1.03-1.27],0.0109579455173753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,19716,339,0.69 [0.59-0.81],2.8709975283362844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,16895,301,0.97 [0.69-1.36],0.849892429216907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,16677,295,0.71 [0.42-1.19],0.1956164804118286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,19939,343,1.66 [1.39-1.98],3.3758658652852955e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,16735,300,0.95 [0.79-1.15],0.6136779699506351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,16636,304,1.11 [0.78-1.56],0.5714584601109689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,16602,297,0.90 [0.71-1.14],0.3675580965650676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,16636,304,1.01 [0.82-1.24],0.952278119471979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,17167,307,1.12 [0.98-1.29],0.0875314315187763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,16787,295,1.01 [0.90-1.13],0.8434961304613906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,16735,300,1.39 [1.08-1.78],0.0107844466047397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,19668,335,0.81 [0.65-1.00],0.0548456341472721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,19332,331,1.34 [1.00-1.80],0.049188779427182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,19565,336,1.31 [1.15-1.49],3.213812040296939e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,17155,308,1.33 [1.03-1.73],0.0313554057437456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,19885,342,0.96 [0.87-1.06],0.4361046843998043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,16725,292,1.06 [0.91-1.23],0.4725522038893699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,16602,297,1.19 [0.89-1.60],0.2337072621460096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,19301,331,1.05 [0.84-1.32],0.6598535858717578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,16735,300,1.13 [0.92-1.39],0.2512820320946523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,17167,307,1.06 [0.95-1.18],0.3127446574319482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,19704,334,1.38 [0.85-2.24],0.1867195772278057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,19628,337,1.24 [1.06-1.45],0.0074750692612487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,17140,308,1.37 [1.07-1.76],0.0124683398720422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,17155,308,1.14 [1.03-1.25],0.0083109608263416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,19332,331,1.02 [0.83-1.25],0.8520691873017717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,16735,300,1.19 [0.92-1.54],0.1965726525448062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,19332,331,1.08 [0.94-1.24],0.2674078034671201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,19332,331,1.09 [0.94-1.26],0.2403292616670325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,19752,333,0.99 [0.85-1.15],0.868757544381026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,20015,341,0.99 [0.88-1.10],0.8098130259499075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,16895,301,1.02 [0.95-1.10],0.5193531592175402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,17155,308,1.06 [0.92-1.21],0.4129848363891073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,19888,341,0.89 [0.75-1.04],0.1506377706715169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,16677,295,1.00 [0.83-1.21],0.9827950004852952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,16602,297,1.01 [0.79-1.28],0.9476715671649044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,16967,304,0.96 [0.77-1.19],0.7084398446767551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,19737,335,1.16 [1.02-1.33],0.0290148626727053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,16636,304,1.06 [0.94-1.18],0.357472040274962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,19939,343,0.65 [0.48-0.88],0.0058040892354535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,16725,292,1.27 [1.03-1.57],0.0242219223492103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,16602,297,0.78 [0.54-1.12],0.1849325186338815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,19592,336,1.02 [0.89-1.17],0.7819856314957431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,17155,308,1.08 [0.89-1.32],0.4143021917255209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,17140,308,1.17 [0.93-1.47],0.1723206425225039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,16735,300,0.81 [0.55-1.18],0.2640531420314917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,17167,307,1.10 [0.96-1.27],0.1651414739656873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,19764,335,2.18 [1.71-2.79],5.079001426682359e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,16725,292,0.89 [0.74-1.07],0.2290335814195587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,20006,342,1.56 [1.21-2.03],0.0006934248397334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,19978,342,0.91 [0.79-1.06],0.2134873444028421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,19733,336,1.18 [0.94-1.49],0.1565128299509587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,20015,341,1.45 [1.18-1.78],0.0004193518655355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,20015,341,1.41 [1.16-1.71],0.0005247878198164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,19699,338,1.22 [1.10-1.35],0.0002288198311085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,19521,336,0.98 [0.85-1.13],0.7474280882801695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,19950,342,1.10 [1.02-1.18],0.015965519089267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,19556,336,0.99 [0.82-1.20],0.9485289480837816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,20006,342,1.44 [1.32-1.57],1.4031093717485746e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,19840,341,2.33 [1.93-2.81],8.78938734269767e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,19542,333,1.75 [1.48-2.08],7.231458744759593e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,19840,341,1.16 [0.92-1.45],0.2121488193238674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,19811,340,1.02 [0.91-1.16],0.6959583067754516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,20006,342,1.32 [1.08-1.61],0.0059506533027872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,19752,333,1.08 [0.98-1.20],0.1262628851586539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,19764,335,1.19 [1.01-1.40],0.0337756390098148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,19689,330,1.42 [1.22-1.66],6.4874521661004095e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,19752,333,1.10 [0.96-1.26],0.1640083530519236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,19771,340,1.02 [0.88-1.17],0.8305340419182328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,19867,338,1.08 [0.98-1.18],0.1391216988302176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,19752,333,1.41 [1.22-1.64],5.279362264856313e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,19911,341,0.96 [0.82-1.13],0.6538961899908686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,19640,333,1.17 [1.02-1.35],0.0232305691173472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,19743,338,1.12 [0.95-1.34],0.1861009189010247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,19979,339,1.79 [1.38-2.31],1.0644361347706907e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,19939,343,1.38 [1.08-1.76],0.0093225592396299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,19776,339,0.90 [0.69-1.18],0.4526658106390255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,16895,301,1.09 [0.81-1.48],0.5681575799555006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,16677,295,0.85 [0.71-1.02],0.0861637835882444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,19592,336,0.96 [0.77-1.19],0.7185253784981958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,19301,331,1.02 [0.81-1.28],0.8727829110450002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,17141,308,1.43 [1.09-1.87],0.0096015483521837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,19776,339,1.39 [1.03-1.88],0.0314862615617297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,19405,329,2.11 [1.68-2.64],7.015741651058716e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,20006,342,0.91 [0.74-1.11],0.3333621478342341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,19867,338,1.90 [1.54-2.34],1.907499232181312e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,19776,339,1.11 [0.76-1.64],0.5822744012671048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,16735,300,1.16 [0.84-1.59],0.3641572765187851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,19743,336,1.01 [0.94-1.10],0.7326449584099589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,19829,337,0.96 [0.64-1.43],0.8434577649721141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,16602,297,0.92 [0.67-1.27],0.6263426969429309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,19752,333,1.16 [0.81-1.67],0.4183839126086927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,19681,332,0.96 [0.72-1.28],0.7905847834478028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,19306,327,1.39 [1.08-1.80],0.0110749496807113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,19829,337,0.86 [0.67-1.12],0.2621691197685305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,20006,342,0.92 [0.73-1.16],0.4875552695895476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,16677,295,0.84 [0.64-1.11],0.2294094437306572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,20006,342,1.00 [0.70-1.43],0.9987873590825002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,17201,308,0.75 [0.57-0.99],0.0397216463580876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,19829,337,1.98 [1.61-2.42],5.863090552784585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,19592,336,1.94 [1.50-2.50],3.165027088188447e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,19740,338,2.13 [1.61-2.81],9.056396869037013e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,19301,331,1.53 [1.22-1.92],0.0002791038580087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,19764,335,1.12 [0.95-1.31],0.167923994362641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,16814,295,1.70 [1.18-2.45],0.0041404121790797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,19950,342,1.92 [1.48-2.50],9.586285823132215e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,19885,343,2.01 [1.62-2.48],1.1747175953656924e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,19939,343,1.61 [1.35-1.91],9.634325123627272e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,19776,339,1.30 [1.00-1.70],0.0516723501442076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,19668,335,2.27 [1.72-2.99],5.9654534504702304e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,19829,337,1.20 [1.05-1.37],0.0069440346838571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,19888,342,0.53 [0.35-0.81],0.0031271095216567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,16677,295,1.18 [0.93-1.50],0.1754405678622613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,19668,335,0.63 [0.46-0.86],0.0035433254495577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,16636,304,1.13 [0.81-1.57],0.4694036977807617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,16895,301,0.94 [0.65-1.35],0.7217719543080088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,16677,295,1.02 [0.89-1.16],0.8034802569194793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,19725,331,1.82 [1.34-2.47],0.0001283904350671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,19742,339,1.41 [1.17-1.70],0.0002821479788607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,20006,342,1.12 [0.99-1.27],0.072030951375334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,19675,335,1.50 [1.07-2.09],0.0173144098527791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,19811,340,2.15 [1.59-2.92],6.900117757031157e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,19911,341,1.40 [1.09-1.80],0.0092498741444957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,19088,318,1.57 [1.08-2.27],0.0184651653249146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,19703,337,1.75 [0.98-3.11],0.0571426676801261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,19085,329,1.52 [1.03-2.24],0.0348363620288507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,17124,305,1.81 [1.44-2.28],3.570250835188729e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,19972,341,1.14 [0.95-1.37],0.1714167256933578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,19556,336,1.31 [1.07-1.60],0.0092508919239876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,19664,334,1.07 [0.95-1.20],0.242497431448214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,16650,294,1.45 [1.14-1.86],0.0029414379050333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,19752,333,1.61 [1.29-2.02],2.614419606063952e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,16814,295,1.20 [0.93-1.56],0.1646104830210568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,19950,342,2.06 [1.59-2.66],3.674462865293992e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,20006,342,1.44 [1.18-1.75],0.0002542052221347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,17199,308,2.52 [1.89-3.35],2.0206768796534844e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,16895,301,1.06 [0.79-1.42],0.7131145893850296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,19752,333,2.28 [1.78-2.93],9.138479154409094e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,19752,333,0.99 [0.73-1.35],0.9410993344201908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,17141,308,1.61 [1.11-2.33],0.0113994155726633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,19950,342,1.11 [0.92-1.35],0.276078890679623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,19057,326,1.46 [1.06-2.02],0.0209381937534704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,19776,339,1.30 [0.79-2.13],0.3063241987335021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,19776,339,2.13 [1.44-3.16],0.0001741843919264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,17170,308,0.80 [0.63-1.02],0.0708544952622494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,17155,308,0.69 [0.40-1.21],0.1997729901652145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,16595,297,0.89 [0.73-1.10],0.2817237377048796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,16595,297,1.09 [0.83-1.45],0.5366977301545057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,17103,307,1.07 [0.91-1.26],0.4310692880844963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,19301,331,1.00 [0.84-1.19],0.9801121777717324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,19829,337,1.05 [0.93-1.18],0.4379625708356868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,17141,308,1.02 [0.91-1.14],0.7006099585080563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,19592,336,1.75 [1.50-2.04],8.216027033582807e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,19112,323,1.22 [0.97-1.54],0.0859514433637629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,19923,342,0.80 [0.68-0.94],0.0056476625716323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,19764,335,1.09 [0.94-1.25],0.2535654530291243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,19764,335,1.77 [1.36-2.31],2.383692745302357e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,16895,301,0.87 [0.57-1.33],0.5266958318514505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,17155,308,1.12 [0.72-1.75],0.6027505965732317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,19950,342,0.94 [0.72-1.23],0.6338890615695378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,16636,304,1.19 [0.95-1.49],0.1327069181314401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,20015,341,0.93 [0.67-1.29],0.6739824586454168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,19764,335,1.06 [0.82-1.36],0.6730445223363875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,19332,331,0.89 [0.69-1.16],0.39168891701329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,19668,335,1.31 [1.12-1.53],0.000788769289574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,19764,335,0.59 [0.47-0.76],2.3734924762518413e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,16595,297,0.89 [0.65-1.23],0.4792025986272848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,17167,307,1.04 [0.85-1.26],0.7254147303860027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,16636,304,1.08 [0.88-1.33],0.4580616126365462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,19668,335,0.94 [0.86-1.04],0.2176106289263394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,19668,335,0.99 [0.89-1.11],0.9148236344219076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,19668,335,0.82 [0.61-1.12],0.2130312863517452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,19768,339,1.47 [1.01-2.15],0.0429745795489858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,19950,340,1.21 [0.97-1.51],0.0938393919369647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,19800,336,5.92 [3.91-8.95],3.896752578265187e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17141,308,0.50 [0.43-0.57],1.2694351664270081e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,16895,301,0.96 [0.81-1.12],0.5951596083136048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17141,308,1.51 [1.14-2.00],0.0037700895448642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,16895,301,1.14 [0.91-1.43],0.2575251818218081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,19752,333,1.11 [0.99-1.25],0.0637733479889212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,19301,331,1.10 [0.89-1.35],0.395649734565231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19054,325,1.62 [1.42-1.85],9.03699142967994e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17201,308,1.87 [1.55-2.25],9.169142309133326e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19402,328,1.48 [1.23-1.77],2.34192760805014e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,16677,295,0.95 [0.67-1.34],0.7594046239625375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,19402,328,1.12 [0.87-1.45],0.3885430772551805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,17201,308,0.92 [0.78-1.08],0.3012097020151687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,19985,341,0.90 [0.77-1.06],0.206285445122509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,16814,295,0.87 [0.58-1.31],0.5103026693339028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,16677,295,1.40 [1.02-1.91],0.0362585205784722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,16636,304,1.06 [0.87-1.30],0.5402996744489896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,16895,301,1.07 [0.87-1.31],0.5352608176408344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,16895,301,1.07 [0.91-1.26],0.3908199531098276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,16602,297,1.15 [0.91-1.43],0.2379884061317498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,16595,297,1.12 [0.86-1.46],0.3895741433114792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,19413,332,1.08 [0.93-1.26],0.3133997332050068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,16725,292,1.14 [0.98-1.32],0.093260841734901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,19301,331,1.04 [0.91-1.19],0.5441893390412309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,16895,301,0.92 [0.73-1.16],0.4784326248295297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,16595,297,0.96 [0.69-1.32],0.7952411085643483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,19248,324,1.00 [0.86-1.16],0.9583607447082416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,19301,331,0.97 [0.83-1.14],0.7359571657664983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,19332,331,1.08 [0.91-1.27],0.386857283604372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,19827,337,1.15 [1.03-1.28],0.0138494282451695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,19668,335,1.23 [1.04-1.45],0.0145749740811223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,19668,335,1.00 [0.87-1.15],0.9894612961664306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,19332,331,0.97 [0.83-1.12],0.650630511210589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,17141,308,1.03 [0.89-1.19],0.6664764225223223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,16916,301,2.18 [1.53-3.09],1.3886941852393491e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,19301,331,0.92 [0.73-1.15],0.4638045426035064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,17206,307,1.65 [1.04-2.60],0.0334426476731833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,16233,291,2.75 [1.67-4.54],6.973897506555753e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,17089,301,1.15 [0.94-1.42],0.1836764992666836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,17174,307,1.11 [0.95-1.30],0.2015144064972487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,16996,303,1.42 [1.08-1.86],0.012844110567346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,17206,307,1.96 [1.11-3.48],0.0207457928910415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,17206,307,0.62 [0.36-1.07],0.0880877436612186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,19776,339,1.51 [1.30-1.75],6.781173643646158e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,17214,308,1.30 [0.94-1.80],0.1187984911424227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,16735,300,1.53 [1.20-1.95],0.0006706630569148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,19764,335,1.58 [1.27-1.97],4.990481530099008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,19301,331,1.03 [0.87-1.23],0.7220785165352679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,16814,295,0.92 [0.72-1.17],0.4756399222419739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17155,308,1.80 [1.44-2.24],2.3401161839449737e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,17140,308,2.24 [1.64-3.06],4.024401733227594e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,19402,328,0.79 [0.58-1.09],0.1552873665773518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,17201,308,1.41 [1.27-1.56],2.4564513070831584e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,19899,342,0.94 [0.74-1.19],0.5999014223472341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,19353,329,1.55 [1.41-1.72],7.073156263456117e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,19854,340,1.06 [0.99-1.14],0.098720003339635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,19840,337,1.38 [1.00-1.90],0.0496026691698789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,16735,300,0.95 [0.78-1.16],0.5941468752248735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,19592,336,0.93 [0.82-1.06],0.3020413124495268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,17199,308,0.93 [0.76-1.13],0.4380016189969629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,16636,304,0.89 [0.75-1.06],0.1998540886127104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,19811,340,2.46 [1.85-3.27],6.738722022018731e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,19764,335,1.21 [0.98-1.49],0.0824409330868794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,16735,300,0.96 [0.69-1.35],0.8265252226220834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,19829,337,1.07 [0.91-1.26],0.4228926356105257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,17201,308,1.61 [1.30-1.99],1.2176701341697422e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,16895,301,1.01 [0.77-1.34],0.9320130652235152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,17141,308,1.05 [0.93-1.18],0.4248691302165994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,16735,300,1.39 [1.11-1.74],0.0042106128674246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,19903,340,2.13 [1.59-2.85],3.4472634240311294e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,17201,308,1.88 [1.56-2.26],1.858703007009921e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",19677,337,1.26 [1.07-1.47],0.0044581286660276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,16595,297,0.94 [0.78-1.12],0.4918970755813733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,19735,334,1.16 [1.01-1.34],0.031092214467778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,19592,336,1.39 [1.05-1.83],0.0206084133617272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,19749,339,1.32 [1.07-1.62],0.0084784041405299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,16677,295,1.61 [0.92-2.82],0.0920479821216796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,19776,339,2.00 [1.48-2.69],4.924553105813934e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,19402,328,1.42 [1.06-1.90],0.0187003191101715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,19950,342,1.06 [0.96-1.18],0.2546500136466351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,16735,300,0.99 [0.78-1.27],0.960807440493184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,16829,300,0.20 [0.11-0.35],1.3272055503042492e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,19752,333,0.70 [0.53-0.91],0.0087390039862885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,19752,333,1.07 [0.87-1.31],0.5431359477547394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,19752,333,1.51 [1.30-1.75],4.318457953035109e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,19752,333,0.75 [0.56-1.01],0.0595108635410504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,17176,308,0.93 [0.74-1.17],0.5323930218090631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,19695,334,2.53 [1.89-3.39],3.6170182577511054e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,19301,331,1.95 [1.61-2.37],1.2225636810980097e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,20006,342,1.12 [0.94-1.34],0.1931146414220612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,16735,300,1.69 [1.37-2.08],7.720831288138768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,16735,300,1.42 [1.04-1.95],0.027285927185257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,16595,297,0.97 [0.76-1.25],0.827036405420202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,19752,333,0.96 [0.88-1.05],0.369069283338171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,19939,343,2.05 [1.35-3.13],0.0007967411752646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,16735,300,0.85 [0.59-1.21],0.3552182634202573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",19565,336,1.13 [1.02-1.26],0.0174787292746771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,19741,338,0.77 [0.68-0.88],0.0001722134077875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,19305,331,0.89 [0.64-1.22],0.4620484642091333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,19332,331,1.16 [0.96-1.40],0.124838739350492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,20006,342,1.84 [1.50-2.26],6.276900075644975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,17155,308,2.29 [1.63-3.20],1.4300896011376168e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,19402,328,0.94 [0.75-1.18],0.59508188137359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,17206,307,1.11 [0.78-1.57],0.5687432658481828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,19724,335,0.99 [0.80-1.23],0.9431390684532208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,17199,308,1.07 [0.95-1.21],0.269132973649028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,17140,308,0.94 [0.82-1.08],0.3713458665986345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,19867,338,0.53 [0.45-0.64],4.708220199238812e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,16636,304,0.97 [0.76-1.23],0.8053063922024004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",16696,292,0.96 [0.83-1.12],0.624977389302714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,19402,328,1.06 [0.91-1.25],0.4442722976276998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,19668,335,1.08 [0.95-1.24],0.2476834056158481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,19764,335,1.04 [0.95-1.14],0.4143807894962309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,16636,304,1.02 [0.73-1.44],0.9021017735609356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,20015,341,0.58 [0.41-0.84],0.0033433470050399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,19939,343,1.10 [0.88-1.37],0.4001200623713375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,19776,339,0.73 [0.52-1.01],0.0594737414723524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,19776,339,1.56 [1.02-2.37],0.0382799932767132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,19821,342,0.61 [0.46-0.81],0.0005410397271734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,19752,333,1.17 [0.93-1.46],0.1717590205806212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,16735,300,0.98 [0.86-1.10],0.6982029024171048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,17199,308,1.40 [1.11-1.75],0.00403463181249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,17201,308,1.58 [1.08-2.31],0.0174315931824618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,19854,340,3.51 [2.37-5.19],3.145705866109238e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,20015,341,1.62 [1.07-2.45],0.0219749020784474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,17141,308,1.27 [1.03-1.57],0.0237390008770916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,16735,300,0.80 [0.68-0.93],0.0031819439268607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,16725,292,0.93 [0.81-1.08],0.3564954071380679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,17201,308,1.96 [1.21-3.15],0.0057860546636405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,19764,335,2.20 [1.76-2.74],3.00817387579201e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,16868,301,1.13 [0.90-1.43],0.2804721373269796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,16814,295,2.09 [1.65-2.63],5.356151744259755e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,20015,341,2.26 [1.79-2.85],7.182622413703508e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,19752,333,1.86 [1.53-2.27],7.974860500734963e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,16895,301,0.93 [0.71-1.24],0.6388269611090575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,19740,338,2.78 [2.01-3.84],6.580594515399219e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,16725,292,0.98 [0.81-1.19],0.850039771559959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,17140,308,0.84 [0.62-1.13],0.244500200727337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,19567,334,1.23 [0.91-1.65],0.1780340151593955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,19179,321,1.11 [0.98-1.26],0.1129675646765234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',16602,297,0.91 [0.69-1.20],0.4988442267942996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,19332,331,0.81 [0.63-1.03],0.0831814364483963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",16725,292,1.40 [1.10-1.79],0.0065031570077183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,19395,328,1.03 [0.93-1.16],0.5548660184860704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,16636,304,1.02 [0.75-1.38],0.9208114819953384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",19668,335,1.30 [1.13-1.49],0.0002035369919272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,17199,308,0.96 [0.68-1.35],0.7977905568730153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,20015,341,1.02 [0.88-1.18],0.8015572236678249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,19896,341,0.80 [0.69-0.92],0.0027849461810867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,16485,292,1.21 [0.92-1.59],0.1797432455096327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,20015,341,1.02 [0.87-1.18],0.8420002388709766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,17178,306,0.82 [0.50-1.36],0.4385720249663315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,19777,340,0.95 [0.74-1.22],0.6867719625182183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,16595,297,0.88 [0.60-1.30],0.5297323449563102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,19853,342,1.54 [1.17-2.03],0.002179118125404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",16677,295,1.27 [0.83-1.95],0.2724519791953994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,19950,342,1.12 [0.96-1.30],0.1455453224548409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,17173,307,1.25 [0.91-1.72],0.1598398229653741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,16602,297,0.91 [0.67-1.24],0.5580216993928324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,19900,343,1.50 [1.17-1.94],0.0017280621138183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,19829,337,1.18 [1.02-1.35],0.0220054330772969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,17199,308,1.76 [1.18-2.61],0.0053073058580649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,17153,308,1.31 [0.95-1.80],0.0999341945594998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,19867,338,0.74 [0.60-0.92],0.0055224633196352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,19301,331,0.98 [0.87-1.11],0.7926076248213497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,19565,336,1.01 [0.88-1.15],0.9131465748597114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,16595,297,1.09 [0.88-1.34],0.437772586067072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,16595,297,0.94 [0.58-1.50],0.7826966596683599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,19518,329,1.90 [1.53-2.36],7.0009879302294995e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,16814,295,1.84 [1.37-2.49],5.84343079771137e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,19811,340,1.25 [1.03-1.51],0.0205119320661287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,19266,331,0.78 [0.69-0.88],5.933516798667751e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,19740,338,1.73 [1.22-2.46],0.002286260118294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,19402,328,1.08 [0.92-1.28],0.3412436944750419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,19840,341,3.88 [2.48-6.06],2.60884932172443e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,19592,336,1.14 [0.87-1.49],0.3362535683365921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,19939,343,0.67 [0.56-0.79],1.548541393765727e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,17058,305,0.71 [0.47-1.08],0.1074483517785442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,19774,339,0.99 [0.90-1.09],0.8540952443807088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,19840,341,1.33 [0.90-1.97],0.1481688921166633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,19220,333,1.18 [1.01-1.37],0.0333324717616514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,20015,341,0.55 [0.40-0.74],0.000119653328548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,19592,336,1.10 [0.91-1.33],0.3464860987697359
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,16735,300,0.91 [0.69-1.20],0.5000766790522493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,19402,328,1.00 [0.90-1.10],0.963687581552096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,17199,308,1.13 [0.95-1.33],0.1598455996938796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,17155,308,1.25 [1.11-1.41],0.0001852504738916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,17155,308,1.09 [0.97-1.22],0.1526068851101306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,16636,304,1.09 [0.93-1.27],0.2866955466497815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,16725,292,1.00 [0.88-1.14],0.9734257850691131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,16602,297,1.01 [0.91-1.13],0.8368489485014252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,19840,341,3.06 [2.22-4.21],6.795275155240256e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,17214,308,1.83 [1.44-2.32],9.271757623343689e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,16602,297,1.28 [0.96-1.70],0.0916805111216245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,19592,336,1.28 [1.09-1.49],0.0023490817354283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,16677,295,1.68 [1.26-2.24],0.0003553906444534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,19413,332,1.12 [0.92-1.37],0.2456772885710317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,16677,295,1.47 [1.03-2.09],0.0314736613957769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,17214,308,1.15 [0.78-1.71],0.4743455654208177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,16677,295,0.99 [0.82-1.20],0.9524932111811836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,17167,307,1.23 [0.96-1.58],0.1047992120562559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,17201,308,1.01 [0.72-1.40],0.969706820412438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,16636,304,0.97 [0.76-1.24],0.7877773967754276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,16602,297,1.09 [0.98-1.23],0.1253322619434871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,14966,255,0.90 [0.79-1.02],0.1011339819711527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,19831,337,1.83 [1.34-2.50],0.0001623544757515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,19341,332,0.97 [0.81-1.16],0.7341966412466516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,19239,328,1.06 [0.86-1.30],0.6120398272455431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,19771,340,1.22 [1.12-1.32],6.097996193376216e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,19510,336,1.59 [1.28-1.96],2.420966044637777e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,16867,300,0.86 [0.67-1.10],0.2210997038871672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,16968,303,0.83 [0.54-1.28],0.3933070456946511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,19402,328,0.98 [0.87-1.10],0.7237917165818515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,17201,308,2.31 [1.58-3.38],1.4604624272935593e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,17201,308,1.24 [0.85-1.81],0.2588038701877589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,16636,304,1.06 [0.75-1.51],0.7404985102413233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,19776,339,0.79 [0.67-0.93],0.0054153442947553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,19736,338,0.85 [0.73-0.99],0.0328232017321082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,17155,308,0.77 [0.67-0.90],0.0009158159895554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,19788,338,1.30 [1.08-1.56],0.0058084217454514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,19695,338,1.53 [1.23-1.91],0.0001222957820294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,18486,309,1.77 [1.46-2.16],1.3096212341724949e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,16814,295,1.12 [0.90-1.39],0.3062286762491997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,19829,337,1.13 [0.89-1.43],0.3193807430082898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,19334,327,1.07 [0.93-1.23],0.3430534429442821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,19764,335,2.53 [1.73-3.71],1.874233220325844e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,20006,342,1.66 [1.23-2.24],0.0010526639414249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,15560,263,2.34 [1.42-3.86],0.0007998877723029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,19868,342,1.07 [0.84-1.37],0.562267065387144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,19807,338,1.77 [1.31-2.39],0.0002158743262694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,16735,300,1.31 [1.01-1.69],0.0391348209835558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,17051,305,1.05 [0.87-1.26],0.60710723380093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,19592,336,1.17 [0.87-1.57],0.3085169288382512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,19752,333,1.95 [1.65-2.31],1.0478876885147796e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,19708,340,0.93 [0.83-1.04],0.1841739493864068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,19840,341,1.25 [1.09-1.43],0.001393074766852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,19950,342,1.35 [1.21-1.51],7.853470004835431e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,19413,332,1.61 [1.25-2.06],0.0001987482560258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,19950,342,1.37 [1.21-1.54],4.054686812044251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,19413,332,1.12 [0.94-1.32],0.2024290163958975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,19982,340,3.05 [2.05-4.53],3.284692905364692e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,20006,342,2.13 [1.80-2.52],1.776701100960609e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,19742,339,0.92 [0.83-1.02],0.1230847080987057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,19693,335,0.91 [0.84-1.00],0.0436665932520863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,20006,342,0.82 [0.72-0.94],0.0035682775203281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,19630,342,1.24 [1.09-1.41],0.0008041818047311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,19840,341,1.38 [1.21-1.57],1.8962051248554748e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,16595,297,1.06 [0.90-1.25],0.4949027203098574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,16962,303,1.40 [1.16-1.68],0.0004554569352451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",16602,297,1.08 [0.95-1.22],0.231469192145306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,16595,297,0.99 [0.84-1.17],0.9108489395577428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,17201,308,1.54 [1.02-2.33],0.0420996882133633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,16814,295,1.00 [0.87-1.15],0.9791599434162004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,19939,343,1.00 [0.92-1.10],0.9390785370586032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,19840,341,1.38 [1.12-1.69],0.0020331171019796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,16677,295,1.04 [0.84-1.28],0.7373692204734243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,16677,295,1.06 [0.88-1.29],0.5304585262049051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,19752,333,0.96 [0.88-1.04],0.2939438716408972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",19565,336,0.91 [0.79-1.05],0.1944509371518714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,17185,308,0.96 [0.87-1.05],0.33894874359017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,19687,336,1.11 [0.98-1.26],0.0991357731311631
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,16677,295,1.05 [0.83-1.33],0.6738218932373272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,19840,341,1.02 [0.91-1.13],0.7636289643509321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",19829,337,2.14 [1.64-2.80],1.8638019379886442e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,16735,300,0.99 [0.61-1.60],0.9561112822003184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,16595,297,1.03 [0.85-1.25],0.7886652874481203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,16595,297,1.14 [0.78-1.66],0.4949424805723815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,19402,328,0.87 [0.56-1.37],0.5567450641254916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,16814,295,0.97 [0.85-1.09],0.5697512524554006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,19939,343,0.90 [0.77-1.05],0.187388848672151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,19668,335,0.85 [0.76-0.95],0.0055133320238385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,19332,331,1.00 [0.87-1.16],0.9792643711475943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,19764,335,1.25 [0.93-1.70],0.1440236664884318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,16636,304,1.08 [0.93-1.26],0.3158965268318883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,16595,297,1.10 [0.96-1.27],0.1629294777531682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,19829,337,0.97 [0.81-1.16],0.7586032744607832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,16602,297,1.19 [0.89-1.60],0.2344091711610412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",19668,335,1.66 [1.36-2.03],7.167333209467507e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,19737,335,1.26 [1.03-1.53],0.0223202772495351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,17167,307,1.02 [0.86-1.22],0.7855304353044497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,16814,295,0.95 [0.81-1.11],0.5315297628763304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,19950,342,2.54 [1.79-3.59],1.6627477972450144e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,17201,308,1.04 [0.80-1.36],0.7757393501251764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,17141,308,1.00 [0.79-1.28],0.979724189924599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,16735,300,0.94 [0.67-1.33],0.7412261817258731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,16677,295,0.79 [0.46-1.34],0.3785780390460439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,16677,295,1.02 [0.82-1.27],0.8667161538305255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,16735,300,1.04 [0.74-1.45],0.8217004872206082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,19301,331,0.95 [0.79-1.13],0.5565121249855525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",19752,333,1.14 [1.03-1.27],0.0148862491033149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,19384,328,1.02 [0.86-1.22],0.7920459262138213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,16556,294,1.23 [0.96-1.58],0.0976290611490194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,16636,304,0.93 [0.74-1.16],0.5056500172965214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,16636,304,1.06 [0.90-1.24],0.5079275999223825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,16636,304,1.04 [0.86-1.25],0.7158463284461078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,19466,330,1.04 [0.97-1.11],0.3007542814806354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,16602,297,1.07 [0.83-1.37],0.6092080920671655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,16677,295,1.00 [0.81-1.23],0.9942509553493044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,20006,342,1.07 [0.92-1.24],0.3826833336493261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,16636,304,1.29 [1.00-1.67],0.0524277498717866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,16677,295,1.11 [0.89-1.37],0.3538289294973883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,19413,332,0.92 [0.69-1.23],0.5764233250681984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,16602,297,0.93 [0.70-1.23],0.6045145718803999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,17140,308,0.89 [0.66-1.20],0.4499373646445266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,17155,308,1.21 [0.96-1.52],0.1151073819290757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",19695,334,1.04 [0.94-1.14],0.4463579885194473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,16735,300,1.03 [0.78-1.36],0.8158781978061578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,16814,295,1.92 [1.34-2.76],0.0004122077796048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,19950,342,1.05 [0.89-1.23],0.595376972564774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,20015,341,0.93 [0.67-1.29],0.6729882019962593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,19558,335,1.14 [0.92-1.40],0.2213625421927452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,19668,335,0.99 [0.87-1.12],0.8372078631802696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,17155,308,0.96 [0.82-1.14],0.655628376346031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,17167,307,0.83 [0.62-1.12],0.218967819627062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,20015,341,0.73 [0.61-0.86],0.0002551579614811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,19829,337,2.27 [1.69-3.06],6.891599004727616e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,16725,292,1.01 [0.89-1.14],0.9206860398962884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,16725,292,1.18 [0.94-1.48],0.1553913445278848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,16725,292,0.95 [0.78-1.16],0.5959400047815393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,16595,297,0.91 [0.70-1.19],0.5003503407868144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,19937,341,1.01 [0.90-1.14],0.8500812710969539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,17155,308,0.99 [0.84-1.16],0.9133047599007094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,19668,335,1.02 [0.91-1.15],0.7498452299335658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,17141,308,1.07 [0.90-1.27],0.4453294921450461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,16814,295,0.96 [0.77-1.19],0.6812721861171496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,16661,294,1.00 [0.87-1.15],0.9739619810767496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,19402,328,0.95 [0.78-1.14],0.5586626527442933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,17155,308,1.01 [0.75-1.35],0.9724012269536556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,16725,292,1.03 [0.90-1.19],0.6355876423227693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,17141,308,1.10 [0.94-1.27],0.2327133262602848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,19701,338,0.58 [0.40-0.85],0.005389176821398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,16636,304,1.04 [0.91-1.20],0.5485441424133213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,17141,308,0.98 [0.89-1.08],0.7295190162014029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,17167,307,1.28 [1.06-1.54],0.0103732324451965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,19592,336,1.08 [0.91-1.27],0.3787707132841391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,17155,308,1.01 [0.83-1.23],0.9083258763590516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,19803,340,1.29 [1.06-1.57],0.0103468306695581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,16735,300,1.23 [0.94-1.62],0.1347890031932606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,16636,304,1.03 [0.94-1.13],0.5482353215830996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,17155,308,0.98 [0.90-1.07],0.6889541256520528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,19764,335,1.04 [0.96-1.13],0.3769606152584939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,19565,336,0.95 [0.77-1.19],0.6655673678452985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,19668,335,1.83 [1.32-2.54],0.000293648589053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,19752,333,1.57 [1.25-1.96],8.735369844768414e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,19411,331,1.01 [0.70-1.46],0.9594137826627076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,19668,335,0.65 [0.49-0.87],0.0036091574573572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,19614,332,1.56 [1.33-1.81],1.5658500254773972e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,20015,341,0.75 [0.51-1.09],0.1352674181365034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,19886,343,1.29 [1.12-1.49],0.000592925559634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,19592,336,1.19 [0.94-1.51],0.1546703421988101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,19668,335,0.97 [0.82-1.16],0.7702156844380535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,19529,336,1.59 [1.21-2.09],0.0008288208734682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,17167,307,0.98 [0.72-1.35],0.919798636336612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,19776,339,1.21 [0.84-1.74],0.3015486601501446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,19878,342,0.97 [0.73-1.29],0.8521570493365205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,19604,334,0.92 [0.74-1.14],0.4286827903395604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,16814,295,0.98 [0.86-1.13],0.8190328932058437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,17102,307,1.56 [1.25-1.94],9.86424243704474e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,16735,300,0.86 [0.69-1.07],0.170412257143437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,19668,335,1.69 [1.19-2.42],0.0037093463494486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,17199,308,1.05 [0.89-1.23],0.5987862200201461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,19402,328,1.01 [0.87-1.18],0.8480079840193098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,17140,308,0.96 [0.73-1.27],0.7866880760508965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,16735,300,0.85 [0.70-1.04],0.1093583746582637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,19332,331,0.96 [0.85-1.09],0.5666085626563476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",17141,308,1.11 [0.99-1.23],0.065750364024535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,17155,308,1.27 [0.99-1.62],0.0560073073851235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,17140,308,0.81 [0.61-1.07],0.1415464318857384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,16735,300,0.92 [0.79-1.06],0.2532286172184153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,17140,308,0.92 [0.71-1.19],0.5354061356105773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,19592,336,1.05 [0.94-1.17],0.3773292223598096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,19916,343,1.83 [1.35-2.46],7.863701657101832e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,19332,331,1.34 [1.02-1.76],0.0377558297118022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17199,308,1.27 [1.11-1.45],0.0003990961822712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",16725,292,1.23 [1.10-1.39],0.0004067602647382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,16602,297,1.32 [1.12-1.55],0.0010194948153115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,16769,300,0.94 [0.68-1.29],0.6931377825196843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,16636,304,1.03 [0.82-1.30],0.799753343672432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,19939,343,1.90 [1.52-2.37],1.3204557725661586e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,19752,333,0.76 [0.68-0.85],1.7882464843665308e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,17140,308,0.65 [0.52-0.80],5.525250284889527e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,16602,297,0.90 [0.63-1.27],0.5349128926959563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,17167,307,1.14 [0.97-1.33],0.1074063732411516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19402,328,2.07 [1.63-2.64],3.991289060246943e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,16725,292,2.46 [1.73-3.50],6.178087094168471e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,16677,295,1.20 [0.94-1.54],0.14133209847961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,17199,308,1.08 [0.95-1.22],0.2230292262534163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,17141,308,1.35 [0.96-1.90],0.0859742545409745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,16895,301,1.12 [0.81-1.55],0.4811584701908107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,19835,337,2.68 [2.03-3.54],4.039439557555554e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,17167,307,1.10 [0.81-1.49],0.5348825800917123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,19744,339,1.92 [1.42-2.61],2.86711074393394e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,19556,336,1.76 [1.35-2.31],3.5217843642304106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,16735,300,1.10 [0.91-1.33],0.3193273691858281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,19710,337,1.00 [0.91-1.10],0.9305585784112412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,19301,331,1.70 [1.33-2.17],2.3377683293919703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,17141,308,1.54 [1.09-2.16],0.0136405899839055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,20015,341,0.15 [0.08-0.28],9.217555451842795e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,19752,333,1.27 [1.11-1.46],0.0003963744736858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,17199,308,1.03 [0.88-1.20],0.7001235676539944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,16725,292,0.96 [0.87-1.06],0.437563452722834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",17155,308,1.08 [0.88-1.32],0.4639588230737675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",17076,308,1.06 [0.96-1.18],0.2332172952470964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,16602,297,1.08 [0.90-1.29],0.4126423610372299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,16725,292,1.19 [0.89-1.57],0.2356397561106813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,19592,336,0.98 [0.82-1.18],0.862719140073704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,16677,295,1.08 [0.94-1.22],0.2733472525634103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,19764,335,1.27 [1.10-1.47],0.0014693969323602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,20006,342,1.05 [0.95-1.16],0.3589568503810433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,17167,307,1.01 [0.84-1.20],0.9496286743450808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,16602,297,1.05 [0.80-1.37],0.7160270338166439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,19413,332,1.10 [0.79-1.52],0.5714405876437412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,17167,307,1.02 [0.89-1.17],0.7839213238149825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,16636,304,1.11 [0.97-1.27],0.1411674371699407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,17199,308,1.93 [1.44-2.60],1.3114929201966444e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,19668,335,1.11 [0.95-1.31],0.1850250719543327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,16602,297,1.10 [0.81-1.48],0.547589410988024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,19413,332,1.30 [1.06-1.60],0.0112182641586131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,15885,280,0.89 [0.71-1.11],0.3065843882071672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,20015,341,1.90 [1.08-3.34],0.0255690804093037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,19760,338,1.09 [0.96-1.24],0.1927212866722055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,19950,342,0.97 [0.83-1.13],0.7012373576635937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,16725,292,0.77 [0.63-0.94],0.0110815008112355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,17140,308,0.86 [0.66-1.10],0.2276635549408727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,16602,297,1.24 [0.83-1.85],0.294974432102614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,16602,297,1.11 [0.85-1.45],0.4628554528645863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,20015,341,1.89 [1.30-2.74],0.0008723761128308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,19840,341,0.71 [0.59-0.85],0.0002066838189513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,16725,292,0.83 [0.60-1.16],0.2774299732551563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19171,328,1.37 [1.22-1.54],1.458368644765959e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,17140,308,1.07 [0.87-1.33],0.5256197599841292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,19301,331,1.31 [1.06-1.61],0.0136213673032261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,19402,328,1.36 [0.85-2.17],0.1940710789593653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,19402,328,1.55 [1.04-2.30],0.0311774292291546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,16725,292,1.24 [1.05-1.47],0.0122177186555818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,16677,295,0.81 [0.55-1.18],0.2657839499261288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,16735,300,1.02 [0.86-1.22],0.7813147148272022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,19735,338,1.12 [1.01-1.25],0.0402858772045585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,17140,308,1.19 [0.96-1.49],0.1102271935325652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,19803,340,0.99 [0.73-1.35],0.96196952183735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,19332,331,1.17 [1.02-1.33],0.0204238343187068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,19051,329,2.23 [1.70-2.92],6.548277876048289e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,16814,295,1.22 [0.82-1.79],0.3254300332358412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,20015,341,2.16 [1.53-3.06],1.4727770809567368e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,19565,336,1.09 [0.80-1.49],0.5666674110799482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,19402,328,1.00 [0.84-1.18],0.9552424040769396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,16895,301,0.93 [0.69-1.26],0.6440602949348796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,19752,333,1.16 [1.03-1.31],0.0152420155428568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,16725,292,1.23 [1.07-1.43],0.004126117470438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,19909,343,1.79 [1.34-2.38],6.713540528134637e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,19829,337,2.16 [1.48-3.17],7.686728520066829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,19662,337,1.65 [1.01-2.71],0.0466816202137782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,19829,337,1.47 [0.98-2.20],0.0607010899646728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,19668,335,1.01 [0.91-1.11],0.8752081921581707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,16735,300,0.94 [0.80-1.11],0.4730165381766995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,16595,297,0.50 [0.33-0.76],0.0009340580876797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,19565,336,1.03 [0.91-1.17],0.5966699465379046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,16895,301,1.15 [0.83-1.59],0.3982150492262034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,16677,295,0.91 [0.70-1.17],0.4518035359300726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,17140,308,1.39 [1.02-1.89],0.0388708237262684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,16814,295,1.03 [0.94-1.14],0.5186680871797049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,19640,333,1.11 [0.75-1.63],0.6022241045365988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,16602,297,0.76 [0.57-1.02],0.0664383278650694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,20015,341,1.29 [0.96-1.72],0.0860549667472954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,19740,338,1.12 [0.85-1.48],0.418249878734374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,16595,297,0.86 [0.67-1.11],0.2499865073544178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,16677,295,0.84 [0.65-1.07],0.1626948305338029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,17155,308,1.08 [0.94-1.24],0.274120673190431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,16595,297,0.70 [0.49-1.01],0.0545367761520019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,16677,295,0.99 [0.87-1.13],0.895347264584792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,16895,301,0.96 [0.66-1.39],0.8243878014085879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,16602,297,1.11 [0.92-1.34],0.2740837742694045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,16602,297,0.76 [0.57-1.00],0.0499960673781019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,19950,342,1.59 [1.12-2.26],0.0101598928546294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,17214,308,1.05 [0.68-1.60],0.835748048808957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,16970,304,0.95 [0.67-1.35],0.7826526354479575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,19776,339,1.17 [0.99-1.40],0.071258785953687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,17206,307,1.15 [0.87-1.50],0.3251836131541299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,17124,305,0.95 [0.61-1.47],0.8133175809198275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,17206,307,0.95 [0.44-2.06],0.9002258135109886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,19811,340,1.12 [0.94-1.33],0.2109124573248788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,19812,341,0.93 [0.64-1.36],0.725978991080011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,19830,338,0.83 [0.60-1.15],0.2581170710053549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,19837,338,2.06 [1.19-3.55],0.0095439025387495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",19740,338,1.35 [1.23-1.48],2.3782655910512967e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",19764,335,1.20 [1.07-1.35],0.0020313955825486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",17199,308,1.36 [1.12-1.64],0.0016177104019601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",20015,341,1.59 [1.34-1.89],1.1906565500560161e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,19880,342,1.18 [1.02-1.36],0.0237147071436997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,19373,327,1.06 [0.89-1.26],0.5067939673238611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,19752,333,1.06 [0.88-1.27],0.5491953620436927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,19764,335,0.98 [0.86-1.13],0.8210036533562736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,17141,308,1.06 [0.90-1.25],0.4816975839921869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,17167,307,1.03 [0.96-1.11],0.373873168034424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,17140,308,1.35 [0.90-2.01],0.150193152674218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,16725,292,0.92 [0.76-1.11],0.3886098437351049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,17199,308,2.34 [1.60-3.42],1.2062268081525826e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,19668,335,1.54 [1.15-2.05],0.0033370316458276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,19737,335,1.22 [0.88-1.67],0.2300090917469662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,17141,308,1.11 [0.97-1.27],0.120392107539325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,20015,341,0.81 [0.57-1.15],0.2400049312846789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,16735,300,1.07 [0.91-1.26],0.4017890500221945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,19945,340,1.12 [0.85-1.48],0.4138881570255027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,20006,342,0.67 [0.52-0.86],0.0019302558254838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,17201,308,2.14 [1.54-2.97],4.903498196393177e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,16735,300,1.03 [0.84-1.27],0.7459308805616274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",19764,335,1.31 [1.16-1.49],1.6427334542046375e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,17199,308,1.07 [0.92-1.24],0.4070960050405715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,19752,333,1.81 [1.48-2.21],7.265389482688665e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,17167,307,1.40 [0.87-2.26],0.1670014924585545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,19776,339,0.89 [0.73-1.08],0.2313430704772633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,19697,333,1.18 [0.98-1.42],0.0816995953595376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,19301,331,1.10 [0.93-1.30],0.2820610651687412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,19801,337,1.38 [1.12-1.70],0.0028389578241429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,17185,308,1.76 [1.40-2.21],1.0043934303829967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,19693,336,0.74 [0.59-0.93],0.0096910749907321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,19764,335,0.78 [0.62-0.97],0.0282656924299064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,19914,341,1.05 [0.86-1.28],0.6117658672266022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,19413,332,0.97 [0.81-1.17],0.7686620083956428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,19776,339,1.26 [1.08-1.48],0.0043961794439292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,19752,333,1.11 [0.96-1.28],0.1719849506347082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,19301,331,1.41 [1.24-1.60],1.585970020708313e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",16602,297,1.20 [1.02-1.42],0.0317439842701987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",16602,297,1.33 [1.10-1.61],0.00398403378721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,19301,331,0.95 [0.81-1.11],0.511948770999131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,19301,331,0.95 [0.76-1.18],0.6289835201563289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,19837,338,1.05 [0.77-1.43],0.7598514878082381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,16821,300,2.28 [1.61-3.23],3.565623010797249e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",17167,307,1.01 [0.87-1.16],0.9154831976952956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,16677,295,1.26 [1.03-1.54],0.0246037160721834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,16677,295,0.78 [0.59-1.04],0.0917914743296355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,19840,341,1.21 [1.07-1.36],0.0030224112517546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,19752,333,1.16 [1.01-1.33],0.0412911598764244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,16677,295,1.11 [0.86-1.42],0.4155923010362701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,19916,343,1.40 [1.30-1.49],1.6887500147013738e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,19904,343,1.38 [1.19-1.60],1.8234232112470488e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,16677,295,0.81 [0.53-1.23],0.3206212493837771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,19413,332,1.23 [0.92-1.65],0.1644733359884541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,16677,295,1.25 [0.97-1.62],0.0845069556022306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,16595,297,1.09 [0.95-1.25],0.2000329173267387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,16568,296,1.03 [0.77-1.39],0.8225752985291447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,19829,337,0.56 [0.42-0.75],0.0001331170161912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,17201,308,0.81 [0.65-1.01],0.0595058498148079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,17155,308,0.95 [0.70-1.29],0.7557836716819566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,19829,337,2.98 [2.02-4.40],3.7111863734233584e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,16814,295,0.85 [0.68-1.06],0.1527462799738535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,17214,308,2.13 [1.83-2.49],5.81780894798622e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,19332,331,1.12 [0.97-1.31],0.1262665795852565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",16636,304,1.10 [0.96-1.26],0.1516637729165298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,16602,297,0.76 [0.59-0.99],0.0444538878426435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,19332,331,1.08 [0.93-1.24],0.3047667203022227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,19734,339,1.14 [1.00-1.29],0.043054125535356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,17167,307,1.12 [1.00-1.25],0.0593082715561528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,19850,339,0.95 [0.87-1.03],0.2192264889554068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,19592,336,1.54 [1.21-1.96],0.0004129851375175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,19592,336,1.12 [1.00-1.25],0.0410070234395633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,19305,331,1.14 [0.95-1.38],0.1673246408411189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,17141,308,1.06 [0.88-1.29],0.5235580395855127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,19301,331,0.99 [0.90-1.08],0.7743306963864867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,19592,336,2.00 [1.42-2.82],6.804615590383882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,19631,335,2.40 [1.61-3.59],1.9847020853759195e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,19301,331,0.72 [0.50-1.02],0.0671329504466834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,20006,342,1.67 [1.27-2.20],0.0002248971013221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,19829,337,1.06 [0.79-1.41],0.7016168852349044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,19332,331,1.02 [0.88-1.19],0.7948888781806998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,19301,331,1.00 [0.74-1.33],0.9803663400077356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,17206,307,1.20 [0.78-1.84],0.4026440948659751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,17155,308,1.24 [0.98-1.58],0.0709701799884896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,17140,308,1.49 [1.10-2.02],0.0099930671743115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,16677,295,0.92 [0.80-1.06],0.2336811804191243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,19757,335,1.87 [1.38-2.53],5.056856849388202e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,19950,342,2.17 [1.57-2.99],2.557228971948116e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,19768,335,1.03 [0.98-1.09],0.1966140944714149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,16568,296,1.57 [1.17-2.12],0.0027623402005035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,19332,331,0.98 [0.76-1.27],0.8714599492327684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,16677,295,0.94 [0.72-1.22],0.6439250171068358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,19752,333,1.00 [0.89-1.13],0.9547812339146908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,19301,331,0.98 [0.88-1.09],0.7235678600875517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,16602,297,1.04 [0.88-1.24],0.6322800155695694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,16735,300,1.07 [0.77-1.50],0.6830476156044765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,19531,336,1.35 [0.91-2.01],0.1374119240099139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,16725,292,1.35 [1.04-1.75],0.0245257823234873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,19811,340,1.43 [1.17-1.74],0.0003678949090752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,16725,292,5.61 [3.58-8.81],6.253269632393237e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,19713,338,3.08 [2.39-3.96],3.5208749909549056e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,17117,307,0.99 [0.87-1.12],0.8550783601639209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,19882,338,1.04 [0.92-1.18],0.547000647039519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,16814,295,1.30 [1.10-1.55],0.0025221172841116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,19829,337,1.50 [1.11-2.01],0.0073420929643429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,19266,331,1.11 [0.86-1.42],0.4216556663569885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",16866,300,1.14 [0.96-1.36],0.1302016336802972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,19950,342,2.03 [1.66-2.49],1.1024212013785309e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",19592,336,0.97 [0.82-1.15],0.7161895001541478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",19939,343,1.23 [1.07-1.40],0.0026535762688293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,19413,332,1.01 [0.86-1.18],0.9125983895665928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,19741,338,1.01 [0.90-1.12],0.9103788895922652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,16735,300,1.10 [0.92-1.32],0.290557386899311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,16636,304,1.04 [0.79-1.38],0.762332015529299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,17140,308,0.96 [0.75-1.22],0.7345569388499131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,16895,301,0.89 [0.73-1.09],0.2786972153011974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,16636,304,1.14 [0.97-1.34],0.1235000715914249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,16595,297,1.03 [0.66-1.62],0.8875320389110599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,16677,295,1.05 [0.81-1.35],0.7314283921821629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,16895,301,1.09 [0.86-1.38],0.4931792892956765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,16725,292,1.24 [1.01-1.52],0.0387837736599266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,16595,297,1.05 [0.87-1.26],0.6129327384329907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,19840,341,0.96 [0.82-1.11],0.559939595990989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,19668,335,2.37 [1.70-3.33],4.828690557710984e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,19939,343,0.58 [0.40-0.85],0.0044148414197654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,19413,332,1.05 [0.83-1.32],0.700412924446949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17199,308,2.77 [1.94-3.96],2.260481758558608e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,19668,335,0.90 [0.56-1.45],0.6691597507954405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,16602,297,0.90 [0.62-1.30],0.5630808949470402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,16439,292,1.14 [0.75-1.74],0.5460346186826263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,17167,307,0.94 [0.60-1.46],0.7821622084907609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,16895,301,1.08 [0.86-1.35],0.5271697617609274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,19892,340,3.00 [2.06-4.36],9.005274075466462e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,16602,297,0.67 [0.51-0.89],0.0050864031669832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,17155,308,1.31 [1.21-1.40],5.485730594682946e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,16595,297,0.79 [0.51-1.23],0.2907231312177618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",16725,292,1.10 [0.94-1.28],0.2357652897952066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,16735,300,1.13 [0.93-1.38],0.2179202307907947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,17122,307,1.23 [1.04-1.46],0.0180024808477468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,19413,332,1.18 [1.01-1.39],0.0428523162769036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,19332,331,1.14 [0.93-1.40],0.2026362391767862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,16602,297,1.04 [0.79-1.36],0.7897523142382108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,17206,307,1.31 [0.84-2.02],0.2324883249725234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,17155,308,1.05 [0.94-1.17],0.3733594460511376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,19301,331,0.94 [0.87-1.02],0.1470496686850317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16390,289,1.53 [1.27-1.85],8.493159461595082e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,16602,297,1.05 [0.81-1.36],0.7041164663038588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",19668,335,1.27 [0.96-1.70],0.0995269800301772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,20015,341,2.29 [1.97-2.66],1.0243662283165068e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,19764,335,1.21 [0.92-1.59],0.1838281814432179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,19332,331,1.32 [1.02-1.72],0.0330179570638684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,17199,308,1.16 [0.96-1.41],0.1122371569325411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,19270,330,0.98 [0.78-1.23],0.8581880269516866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,19301,331,1.25 [1.07-1.45],0.0047690775649693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,19301,331,0.97 [0.89-1.06],0.4676212915398408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,19916,343,2.59 [1.91-3.52],1.0178473359351004e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,19668,335,1.81 [1.11-2.95],0.0180637827047319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,19529,334,0.86 [0.60-1.24],0.4338254201297232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,16669,292,0.77 [0.64-0.94],0.0093780515251508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,19332,331,1.13 [0.98-1.31],0.0831451304181392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,17199,308,1.02 [0.87-1.20],0.8297743798130732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,17171,307,1.05 [0.83-1.34],0.6744552717819332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,19440,331,1.37 [1.04-1.80],0.0272912332370716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,19744,339,1.82 [1.56-2.12],1.4207787766660836e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,19592,336,3.42 [2.36-4.95],7.285877441295446e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,19737,335,1.10 [1.04-1.16],0.0008987467607495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,19301,331,1.04 [0.98-1.11],0.2174123269645658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,16814,295,0.41 [0.28-0.61],1.2630392236233023e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,19332,331,1.03 [0.85-1.24],0.7878372887005861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,19764,335,1.01 [0.89-1.14],0.9216783368226674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,17167,307,0.99 [0.71-1.38],0.9328590065565926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,17167,307,1.11 [0.95-1.28],0.1855906749966704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,16814,295,1.02 [0.72-1.45],0.8911443963259651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,16595,297,1.13 [0.91-1.41],0.2773765218630453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,16725,292,1.12 [0.89-1.41],0.336968893943021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,17155,308,2.04 [1.50-2.77],5.554945753630061e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,17141,308,1.03 [0.91-1.15],0.6614527916055124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,16677,295,1.09 [0.85-1.40],0.4780473814706786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,16677,295,1.00 [0.88-1.13],0.9960780113762492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,16595,297,1.05 [0.86-1.28],0.6202727409129278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,18986,323,1.53 [1.05-2.22],0.0273432631079725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,16787,295,1.62 [1.20-2.17],0.0014325001174558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,19592,336,1.31 [1.04-1.65],0.020688628861033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,16677,295,1.13 [0.78-1.64],0.5084467045172375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,19402,328,1.53 [1.29-1.82],1.8213226942730485e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,19705,338,1.23 [0.92-1.64],0.1694248950512462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,16636,304,1.15 [0.84-1.57],0.3913978456435436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,19639,333,1.07 [0.90-1.27],0.4647365185788666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",16814,295,1.13 [1.00-1.29],0.0555087524094736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,19332,331,0.96 [0.75-1.22],0.7180215853144567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,17140,308,1.06 [0.87-1.28],0.5918812025940243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,16786,300,1.72 [1.39-2.15],1.0849470558068358e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,17199,308,1.00 [0.86-1.18],0.9733905032208156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,20006,342,0.81 [0.66-0.99],0.0414798482093992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,16814,295,1.01 [0.84-1.20],0.9418701545193644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,17167,307,1.08 [0.95-1.22],0.2374800241800585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,19301,331,1.06 [0.91-1.24],0.4433605848419774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,16735,300,0.96 [0.75-1.23],0.7499089880482122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,19776,339,1.15 [0.96-1.39],0.1259166521343004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,16725,292,0.73 [0.50-1.06],0.0980830594728492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,16814,295,0.90 [0.66-1.23],0.5014561413650183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,17167,307,1.02 [0.88-1.19],0.7676337413947322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,19950,342,2.25 [1.55-3.26],1.922795206094807e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,19752,333,1.00 [0.91-1.11],0.9605627802178006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,17141,308,1.03 [0.81-1.31],0.8337671216035063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",17201,308,1.34 [1.06-1.69],0.0130053939370233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,19704,336,1.01 [0.75-1.36],0.9455676304846844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,16602,297,1.01 [0.86-1.20],0.8760027421849436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,19139,322,0.99 [0.87-1.13],0.8795178032757519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,16814,295,0.91 [0.67-1.24],0.5449980733600309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,19741,338,1.03 [0.92-1.15],0.6669405256870822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,19668,335,1.03 [0.96-1.11],0.4259794871333726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,19939,343,0.59 [0.42-0.83],0.0022496940079651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,19592,336,0.64 [0.53-0.76],9.613159278770222e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,17140,308,1.31 [1.07-1.59],0.0075799626817781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,17141,308,1.05 [0.81-1.37],0.7113321827558398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,17214,308,1.19 [0.95-1.49],0.1332450917847408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,17141,308,0.98 [0.84-1.14],0.7887661555231121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,19332,331,1.33 [1.00-1.77],0.05145940251309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,19222,323,1.19 [0.84-1.70],0.3262967823020581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,16636,304,1.07 [0.89-1.30],0.4654843295534435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,17167,307,1.09 [0.79-1.50],0.5952129458352386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,17141,308,1.29 [1.08-1.54],0.00524876491924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,19402,328,1.34 [1.15-1.56],0.0002104680605679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,17140,308,1.45 [1.22-1.71],1.4862726975220268e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,19764,335,0.99 [0.92-1.07],0.8678349824117897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,17199,308,1.14 [0.95-1.37],0.1519427744881511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",17167,307,1.07 [0.82-1.39],0.6249341291116083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",16636,304,0.87 [0.68-1.11],0.2638946187324619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,19402,328,0.90 [0.72-1.13],0.3631257271543577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,19673,336,1.96 [1.38-2.79],0.0001712836383983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,16725,292,0.93 [0.75-1.15],0.4742945357140724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",19668,335,1.68 [1.47-1.92],4.857389376347047e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,16509,295,1.03 [0.89-1.19],0.6943146278755971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,19301,331,1.00 [0.89-1.13],0.9863021372767936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,17144,308,0.36 [0.21-0.62],0.0002623945071407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",17125,307,1.54 [0.95-2.47],0.0773163070424426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,19735,334,0.97 [0.86-1.09],0.5828497359858346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,19301,331,0.98 [0.86-1.12],0.7698277527676918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,16602,297,1.08 [0.93-1.27],0.3173399308520381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,19205,327,0.94 [0.80-1.10],0.4352676263492253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,17155,308,0.96 [0.91-1.00],0.0665389260447939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,16895,301,1.10 [0.94-1.28],0.2286240732778708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,16735,300,0.95 [0.82-1.09],0.460041185841084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,19672,338,1.32 [1.01-1.74],0.043629428911728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,16895,301,1.07 [0.93-1.23],0.3602189042738913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,16602,297,1.06 [0.82-1.38],0.6525708613765002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,19854,339,1.49 [1.28-1.75],6.381400771388105e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",19402,328,1.06 [0.95-1.18],0.3074769934095037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,20006,342,1.30 [0.98-1.71],0.0647006836342849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,19752,333,0.91 [0.78-1.06],0.2282682755471721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,19402,328,1.07 [0.95-1.21],0.2745463521666712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,16595,297,0.86 [0.65-1.13],0.2730442359827095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",16602,297,1.02 [0.87-1.21],0.7927703498780715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",19888,341,1.01 [0.88-1.17],0.8513514130365613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,19939,343,1.10 [1.01-1.19],0.0206573199705822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",19776,339,1.05 [0.92-1.20],0.4409478320844664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,19911,341,1.73 [1.52-1.96],1.3812452237729085e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,19776,339,2.07 [1.62-2.66],8.977719357021849e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,19888,341,0.89 [0.78-1.02],0.0881585440712045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,19939,343,0.90 [0.76-1.07],0.2327184550678782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,17199,308,0.98 [0.88-1.09],0.7057979985727205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,16602,297,1.02 [0.83-1.25],0.8409546689853253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,20006,342,1.11 [0.92-1.33],0.2773941874542778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,16677,295,0.97 [0.78-1.20],0.7470208041027757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,16636,304,1.00 [0.83-1.19],0.9659945643337224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,17141,308,0.85 [0.66-1.11],0.228500183623047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,19907,342,1.10 [0.98-1.22],0.09683253095819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,17155,308,0.99 [0.83-1.19],0.953204429757224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,19402,328,0.99 [0.81-1.20],0.8971849041032037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,16814,295,2.78 [1.88-4.11],3.21106411874982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,17155,308,0.81 [0.63-1.05],0.1065724228517107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,17199,308,1.71 [1.10-2.64],0.0163961151319196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,19752,333,1.08 [0.95-1.23],0.2228449591332685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,20006,342,2.71 [2.16-3.39],4.363208392660563e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,17067,305,0.78 [0.53-1.17],0.2293095791776381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,19301,331,1.12 [0.98-1.28],0.0847554119650238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,17155,308,1.06 [0.92-1.23],0.4192163469448633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,16677,295,0.93 [0.76-1.14],0.4825164308013148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,16602,297,0.84 [0.58-1.22],0.3542459409707009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,17121,307,1.43 [1.18-1.73],0.0002063741914972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,17167,307,1.29 [1.00-1.66],0.0523232358842944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,19402,328,0.89 [0.60-1.30],0.5326212590419708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",17167,307,1.18 [0.83-1.67],0.3580287161381675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",19691,330,1.36 [1.04-1.78],0.0260401788187259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",19752,333,1.90 [1.40-2.59],4.724703454353002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,19939,343,1.16 [0.90-1.49],0.2417584069511501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,16786,294,1.13 [0.92-1.39],0.2356065710718762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",16725,292,1.31 [1.05-1.64],0.0187453961970071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",16602,297,1.12 [0.86-1.46],0.3989068587995439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,16557,296,1.11 [0.87-1.42],0.3905317369831103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,19544,333,1.10 [0.91-1.33],0.3314920168353076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,19332,331,1.30 [1.08-1.58],0.0069633040621814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,16735,300,1.08 [0.93-1.25],0.2963235950763337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,19506,336,1.35 [1.11-1.65],0.0029718535533177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,19329,326,1.05 [0.92-1.20],0.4688644877332839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,17167,307,1.28 [1.04-1.57],0.0207528245727299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,20006,342,1.00 [0.88-1.15],0.9778348928017992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,19301,331,0.48 [0.36-0.63],1.429494368207256e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,16991,306,1.16 [1.03-1.31],0.0153493708603483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,16865,301,1.00 [0.89-1.13],0.988062094550904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,16725,292,0.92 [0.65-1.29],0.6208989297257549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,17124,305,0.99 [0.70-1.39],0.9432813574788188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,16725,292,1.02 [0.90-1.16],0.7763319904885368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,19668,335,1.06 [0.81-1.38],0.6938034169265082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,19939,343,0.88 [0.66-1.16],0.35873224733796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,16677,295,0.79 [0.57-1.09],0.1439430967585218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,16725,292,0.90 [0.80-1.02],0.1100024101897652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,19752,333,1.67 [1.31-2.13],2.8330223384961124e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,17155,308,1.06 [0.88-1.28],0.5186087391168839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,16602,297,1.00 [0.78-1.28],0.9831334054232198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,16725,292,1.15 [0.91-1.46],0.2346115419252884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,19242,327,0.91 [0.76-1.09],0.2818381369011206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,19803,340,1.12 [0.98-1.29],0.0930858024051638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,17140,308,1.15 [0.84-1.57],0.3946498366089166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,19454,329,1.05 [0.90-1.22],0.5432047836425629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,19939,343,1.20 [0.95-1.53],0.1283703241688824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,19635,332,2.24 [1.64-3.06],3.313758831246536e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,16636,304,1.05 [0.90-1.21],0.5563368460763287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,16636,304,0.98 [0.74-1.30],0.8969297520901255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",19829,337,1.26 [1.07-1.47],0.0048867564744651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,19686,335,3.26 [2.20-4.82],3.5432400624598582e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,20015,341,1.03 [0.67-1.57],0.9057374978719244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,19413,332,1.00 [0.88-1.14],0.9433745529621668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,19695,335,3.71 [2.80-4.92],6.973375208370703e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,20015,341,1.51 [1.11-2.06],0.0092995866856785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,20015,341,1.99 [1.42-2.79],6.873485085599311e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,19752,333,0.98 [0.81-1.19],0.8387034672182764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,19764,335,2.35 [1.90-2.92],7.963308762946278e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,19668,335,0.55 [0.33-0.92],0.022953674334563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,16895,301,1.14 [0.89-1.47],0.3067938350362557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,19332,331,1.07 [0.86-1.33],0.5194683490181338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",16725,292,1.08 [0.91-1.29],0.3737394737077919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,20006,342,0.45 [0.16-1.28],0.1338466373778295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,19939,343,1.56 [1.26-1.93],5.137166961789377e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,16730,300,2.38 [1.88-3.02],6.853738399248126e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,16895,301,1.07 [0.84-1.35],0.587531642962015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,16895,301,1.13 [0.86-1.50],0.3794601471762081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,17141,308,1.42 [0.92-2.18],0.1099574247419898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,19413,332,1.10 [1.01-1.20],0.0310905655126171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,19840,341,1.68 [1.10-2.55],0.0155440745553144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,19592,336,1.37 [1.14-1.64],0.0006625095520989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,19332,331,1.12 [0.92-1.37],0.2709986223806856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,16636,304,1.13 [0.95-1.34],0.1643253486069177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,19752,333,1.22 [0.93-1.58],0.1480201443104244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,16602,297,1.02 [0.73-1.42],0.9125355018525472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,16735,300,1.04 [0.78-1.38],0.790316260106858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,17167,307,1.08 [0.89-1.30],0.4343286943729252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,16636,304,1.08 [0.87-1.34],0.4667376593398563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,17201,308,0.78 [0.52-1.16],0.2183372776426007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,19668,335,1.69 [1.09-2.63],0.0192514780798588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,16602,297,0.86 [0.63-1.17],0.3320144598469171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,19776,339,2.44 [1.64-3.61],9.254686967832378e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,19985,341,1.34 [1.24-1.45],3.9973558196711384e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,19988,341,1.72 [1.47-2.02],2.562781723543621e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,19867,338,0.36 [0.28-0.46],1.129641878893265e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,19530,336,1.78 [1.48-2.14],9.580763764224712e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,19701,336,0.85 [0.62-1.17],0.3253094062598236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,20015,341,2.60 [2.07-3.28],4.651100386537242e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,19764,335,2.82 [2.20-3.62],3.225208005780733e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,16677,295,0.97 [0.82-1.14],0.6717521062055827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,16602,297,1.08 [0.88-1.34],0.4484878133077862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,17187,306,2.40 [1.84-3.13],1.3664722217511628e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,16595,297,0.90 [0.77-1.05],0.1700280416130172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,16725,292,0.86 [0.63-1.17],0.3373835595954152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,19668,335,1.78 [1.45-2.18],3.736565585404138e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,19764,335,1.74 [1.30-2.35],0.0002413247064267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,17199,308,1.29 [1.14-1.45],4.263966867913008e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,19752,333,0.95 [0.85-1.07],0.4168713640568015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,19301,331,1.02 [0.90-1.16],0.7159791264350694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,19413,332,0.98 [0.86-1.12],0.7660735451050549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,19413,332,1.10 [0.93-1.30],0.2900771560596801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,19840,341,2.55 [1.94-3.37],3.5007115479422806e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,19413,332,1.16 [1.00-1.35],0.0526296457509673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,19668,335,1.08 [0.95-1.23],0.2361830695190488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,20006,342,1.05 [0.88-1.24],0.6119556823812208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,19413,332,1.33 [1.01-1.75],0.0404301977051077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,16677,295,1.21 [0.92-1.58],0.1720403685547877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,19413,332,0.96 [0.76-1.21],0.7402597987684225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,19539,332,0.93 [0.61-1.42],0.7354415502963945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,16636,304,1.39 [0.92-2.10],0.12034614112145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,19752,333,2.43 [1.84-3.21],4.030377840081965e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,19413,332,1.43 [1.07-1.91],0.0158889370869045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,20006,342,1.03 [0.82-1.28],0.8252770297682323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,19370,331,1.29 [1.07-1.56],0.0086631581726764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,19413,332,1.34 [1.18-1.53],6.97214737934045e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,19413,332,1.18 [0.91-1.54],0.218237453634881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,19413,332,1.08 [0.94-1.23],0.2852005416403691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,19776,339,1.09 [0.87-1.36],0.4532727141538205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,19504,329,0.81 [0.67-0.98],0.0289349062338057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,19673,336,1.79 [1.45-2.20],5.164367819215883e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,19867,338,2.53 [1.92-3.34],5.5347224385924955e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,20006,342,1.54 [1.16-2.04],0.0026140443889028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,19466,336,1.01 [0.95-1.07],0.6989700961240234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,19269,329,1.50 [1.34-1.69],4.661941856607088e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,19413,332,1.02 [0.86-1.21],0.837411989372324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,19315,329,1.27 [1.09-1.48],0.0017484805701717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,19744,339,2.09 [1.41-3.08],0.0002264974651344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,19703,338,1.54 [0.94-2.55],0.0893664310374854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,19776,339,0.56 [0.44-0.72],3.01191034740018e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,19945,340,2.14 [1.75-2.63],3.04683179102516e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,19413,332,0.36 [0.28-0.47],7.0727516663846e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,19699,339,1.56 [1.34-1.81],6.022191762477085e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,19413,332,1.16 [0.83-1.62],0.3816177669287349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,19413,332,1.03 [0.84-1.27],0.7784367246194045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,19413,332,0.89 [0.69-1.15],0.3754795252687773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,16677,295,0.72 [0.54-0.96],0.0250641213692283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,16677,295,1.08 [0.87-1.33],0.4878215533711234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,17140,308,1.57 [1.36-1.80],4.594631513781533e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,19413,332,1.09 [0.86-1.37],0.4768557587638949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,19413,332,1.07 [0.85-1.33],0.5767785649886739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,16539,296,1.04 [0.73-1.47],0.8292297328491036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,19630,336,2.31 [1.86-2.86],2.2993143111051102e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,19413,332,0.79 [0.58-1.08],0.1414966972452159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,17140,308,1.23 [0.90-1.67],0.1978885608572026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,16595,297,1.09 [0.89-1.34],0.3961174413240499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,16677,295,1.19 [0.98-1.43],0.0764745963685351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,16616,292,1.04 [0.76-1.42],0.8026472699464344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,19752,333,1.57 [1.29-1.91],6.136946333188246e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,19413,332,0.96 [0.73-1.25],0.7452752587895626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,19300,328,1.36 [1.02-1.83],0.0389807915101081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,16677,295,1.27 [1.08-1.50],0.0042937966766224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,16624,295,1.21 [1.05-1.41],0.011039775031832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,19413,332,1.31 [0.95-1.80],0.1027293780845787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,19413,332,0.98 [0.88-1.10],0.7878879567838868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,19752,333,2.11 [1.69-2.64],6.395355298920328e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,19413,332,0.95 [0.88-1.03],0.1959769262036937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,19752,333,1.12 [0.94-1.33],0.1973895460778086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,19668,335,1.56 [1.42-1.72],8.558274129024152e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,19671,335,1.06 [0.79-1.42],0.6817805930228396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,19764,335,3.38 [1.97-5.81],1.0633285581338787e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,19752,333,0.97 [0.83-1.14],0.7117131062711737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,19776,339,0.79 [0.66-0.95],0.0108716175012221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,16895,301,1.07 [0.87-1.31],0.5485663108548429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,19296,329,1.08 [0.90-1.29],0.417434668138358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,17140,308,1.56 [1.25-1.94],8.426428210324442e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,19592,336,0.95 [0.80-1.12],0.5195974117774653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,17155,308,1.10 [0.89-1.35],0.399482926489307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,16636,304,1.13 [0.78-1.65],0.5084742573579903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,19305,331,0.88 [0.70-1.11],0.2898522363974205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,16814,295,1.72 [1.41-2.09],6.114858284305331e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,19776,339,1.14 [0.88-1.49],0.3222674136612355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,19668,335,0.94 [0.78-1.14],0.5501024609099199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",16725,292,1.09 [0.89-1.33],0.4093284743574908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",17167,307,1.00 [0.76-1.33],0.9811177304543872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",19668,335,1.01 [0.91-1.13],0.8021869938702059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,17155,308,0.66 [0.58-0.74],2.4267464640972124e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,17140,308,1.04 [0.81-1.32],0.7784719791159969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,17141,308,1.14 [1.02-1.27],0.020620557342497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,16677,295,3.72 [2.01-6.90],2.9842419283082344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,19556,336,1.06 [0.95-1.19],0.2977363045269384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,19668,335,1.09 [0.90-1.31],0.373222972249656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",19402,328,1.01 [0.90-1.13],0.8594785603876439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,19413,332,1.04 [0.90-1.20],0.6131676573947302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,19752,333,0.99 [0.90-1.10],0.9121524043890578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,19061,326,1.12 [0.86-1.46],0.3886715749115393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,19752,333,1.32 [1.02-1.69],0.0328617777105288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,17201,308,1.00 [0.77-1.29],0.9748097791455383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,17012,306,1.05 [0.93-1.18],0.4312355959166033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,19752,333,0.59 [0.44-0.78],0.0003155102389543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,16814,295,0.69 [0.49-0.97],0.0332219078261063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,19776,339,3.17 [2.19-4.59],1.0368924154687995e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,19752,333,0.98 [0.80-1.19],0.8331688568657926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,16677,295,1.47 [1.11-1.95],0.0071472179383928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,19776,339,0.68 [0.50-0.93],0.017140246361598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,19939,343,0.30 [0.17-0.52],1.6607897587666657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,16895,301,1.25 [1.03-1.53],0.0259077168354608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,19764,336,1.43 [0.91-2.25],0.1255805886023915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,19301,331,1.09 [0.85-1.40],0.4931429731594818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,19402,328,1.04 [0.95-1.14],0.4080488876008526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,19664,337,0.73 [0.52-1.04],0.0774351927751156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,19829,337,1.18 [0.92-1.51],0.1957831600667058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,19413,332,0.90 [0.64-1.25],0.5234805926742929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,19939,343,1.37 [1.12-1.67],0.002156811402018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,17201,308,2.15 [1.71-2.72],8.926065791407451e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,17206,307,0.86 [0.46-1.61],0.6404496193542335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,19867,338,2.53 [1.95-3.29],3.505078929119548e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,17206,307,1.84 [1.25-2.71],0.0021156514039335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,17140,308,1.28 [1.00-1.64],0.0468819693789642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,19752,333,0.97 [0.82-1.14],0.6785672974347572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,16602,297,1.13 [0.95-1.35],0.1558856943907729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",16725,292,0.98 [0.83-1.17],0.8457450907643105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",16636,304,1.12 [0.87-1.46],0.3766405451377623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",19332,331,1.08 [0.89-1.32],0.4409387228437841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,16595,297,1.09 [0.86-1.38],0.470716576461334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,19950,342,0.92 [0.63-1.33],0.657068267849918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,16814,295,1.17 [0.94-1.46],0.1636618301787507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,19413,332,1.42 [1.21-1.68],2.2148851084012566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,16595,297,0.82 [0.65-1.03],0.086767880015185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,17141,308,1.05 [0.92-1.20],0.4624818385146089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,19413,332,1.02 [0.82-1.27],0.8510079838364374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,19668,335,0.81 [0.65-1.00],0.0475339113288399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,17141,308,1.01 [0.91-1.13],0.8010716201767557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,16636,304,1.11 [0.90-1.36],0.3267058617348185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,16735,300,0.96 [0.81-1.15],0.6639226631726829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,19332,331,0.89 [0.71-1.12],0.3330165550420323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,16833,303,1.17 [0.93-1.48],0.1798729501616178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,16677,295,0.94 [0.80-1.10],0.454554781897837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,19829,337,0.90 [0.61-1.33],0.591376379578753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,19332,331,1.15 [0.87-1.52],0.3128864934663512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,16595,297,0.86 [0.71-1.04],0.1250026233644374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,16725,292,1.09 [0.90-1.31],0.3743821981631708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,17155,308,1.01 [0.70-1.45],0.9508485369364208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,16895,301,1.00 [0.84-1.19],0.9962554561212816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,16895,301,1.04 [0.69-1.56],0.8497169109257868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,17140,308,1.08 [0.88-1.33],0.4402449034958983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,16602,297,1.28 [0.95-1.71],0.1021580043185198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,16636,304,1.04 [0.89-1.22],0.6281326927266422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,16602,297,1.03 [0.94-1.13],0.55024514019539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,19668,335,1.01 [0.89-1.14],0.918784639477662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,17140,308,1.15 [1.01-1.31],0.0303113396516715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,19301,331,1.14 [1.00-1.30],0.0547984727506752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,17141,308,1.02 [0.95-1.09],0.599630708806559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,19301,331,1.03 [0.95-1.11],0.4833083434147313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,16595,297,1.16 [1.03-1.30],0.0135706194712293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,16636,304,1.07 [0.88-1.29],0.5062496929429796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,19332,331,0.92 [0.71-1.19],0.5228255237476811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,19837,338,0.49 [0.35-0.68],2.152234197077663e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,19764,335,0.48 [0.38-0.61],1.449622522882301e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,19332,331,0.91 [0.79-1.04],0.1645449294061772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,16636,304,1.44 [1.12-1.86],0.0043320997363564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,17167,307,1.02 [0.82-1.28],0.8363370537445398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,19603,331,1.09 [1.01-1.17],0.0237326130842271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,19780,335,1.79 [1.45-2.22],7.487859366536403e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,19641,335,1.79 [1.40-2.29],3.951453536532958e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,19301,331,0.99 [0.92-1.07],0.7785603641667809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,19294,324,1.06 [0.85-1.33],0.5791593236880037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,19939,343,1.30 [1.07-1.60],0.0101411774665752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,17103,307,1.19 [0.96-1.47],0.1188086977019656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,17201,308,0.79 [0.71-0.88],3.1487988134162465e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,19939,343,1.43 [1.24-1.63],3.375281518559992e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,19789,337,0.78 [0.57-1.08],0.1333944251763715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,16401,293,0.94 [0.70-1.27],0.6826753438579016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,19110,324,1.58 [1.21-2.08],0.0009350494525677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,16864,304,0.65 [0.41-1.04],0.0704267079212261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,20006,342,0.80 [0.62-1.02],0.07685907165204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,16636,304,1.06 [0.89-1.27],0.4942657121756241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,20006,342,1.14 [0.93-1.40],0.204256210946392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,16677,295,1.22 [0.95-1.57],0.1137240599548552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,17155,308,1.08 [0.85-1.38],0.5284473328232755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",18738,316,0.67 [0.45-1.00],0.050367840990749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",16602,297,0.99 [0.73-1.34],0.9498455641457146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",19668,335,1.21 [1.08-1.34],0.0006920960037824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",19716,332,1.22 [1.07-1.40],0.0030081397539493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",19332,331,0.85 [0.69-1.04],0.1088431755951512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",16602,297,1.20 [0.89-1.63],0.231901691083659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",16636,304,1.21 [1.07-1.36],0.0015687314781188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,19731,334,1.14 [0.96-1.35],0.1406655668621013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,20006,342,1.26 [1.02-1.55],0.0298673702382501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,19829,337,1.19 [0.85-1.67],0.3014262275979844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,17199,308,1.15 [1.01-1.30],0.0325927906971718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,17106,308,1.09 [0.85-1.39],0.4978353003216637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,19764,335,1.09 [0.94-1.27],0.2691135401961149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,19668,335,0.90 [0.71-1.14],0.371320889094578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,19740,338,1.73 [1.41-2.13],1.6081549374839224e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,19592,336,1.06 [0.96-1.17],0.2475773086952338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,16602,297,1.06 [0.86-1.31],0.57075291937862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,19840,341,1.60 [1.22-2.11],0.0007302335276176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,16725,292,0.99 [0.68-1.43],0.937312191214994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,16725,301,1.73 [1.34-2.22],1.982892795157352e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,19158,330,1.70 [1.03-2.81],0.0392592331591514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,19972,341,1.84 [1.56-2.18],8.956532314067217e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,17140,308,0.87 [0.66-1.16],0.357600448760489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,19413,332,1.21 [0.99-1.48],0.0612554135259284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,17140,308,1.19 [1.00-1.41],0.056433799874234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,20006,342,1.04 [0.91-1.18],0.5979627029894505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,19668,335,1.02 [0.94-1.10],0.6742363457765399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,16677,295,1.03 [0.90-1.18],0.6837459631762431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,19565,336,1.89 [1.47-2.43],5.478811665587248e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,19867,338,1.45 [1.23-1.71],1.1184345136916158e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,19950,342,1.19 [1.05-1.35],0.0079721645862594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,17214,308,0.35 [0.22-0.57],2.4514609274108263e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,17167,307,1.15 [0.97-1.36],0.103430222520921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,19172,323,1.40 [1.11-1.75],0.0040400315186958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,17201,308,1.05 [0.83-1.32],0.6945324283763259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,19823,337,0.73 [0.60-0.88],0.0011854568453442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,17167,307,1.01 [0.90-1.13],0.9024306556636732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,17199,308,1.28 [1.09-1.50],0.0029922712274127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,19916,343,0.85 [0.71-1.02],0.0849552941403638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,16262,282,1.36 [1.16-1.59],9.979950892786574e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,16636,304,0.99 [0.84-1.17],0.9272055552126226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,17167,307,1.67 [1.24-2.24],0.0007025241260375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,19764,335,1.07 [0.93-1.23],0.3543730394945177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,19764,335,2.05 [1.54-2.71],6.006700424287515e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,17167,307,1.36 [1.12-1.65],0.0017700060083065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,19764,335,1.28 [0.98-1.68],0.0708162282640134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,19828,340,1.73 [1.26-2.38],0.0006735380391386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,17206,307,2.55 [1.90-3.42],3.6457886929799454e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,19740,338,1.94 [1.66-2.27],1.10920748275262e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,19715,340,1.31 [1.06-1.61],0.0119668546210084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,19950,342,1.05 [0.89-1.23],0.5591727849485808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,19742,339,2.36 [1.78-3.12],1.771316315743986e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,19840,341,2.30 [1.78-2.97],2.3744913455318636e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,19301,331,1.05 [0.93-1.17],0.4312549374476607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,19768,340,1.17 [0.99-1.37],0.062136571594922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,19332,331,1.25 [1.03-1.50],0.0225215123191186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,19752,333,2.91 [2.03-4.18],7.250222896012421e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,19776,339,1.79 [1.35-2.39],6.848900433960803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,17201,308,1.01 [0.93-1.10],0.8196673904630954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,16602,297,1.09 [0.87-1.38],0.4523449679118081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,19737,335,2.36 [1.75-3.17],1.3931313721367637e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17199,308,1.25 [1.07-1.46],0.0050953870236574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,20015,341,1.75 [1.22-2.50],0.0023678596303499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,19918,340,1.72 [1.28-2.33],0.0003950867910606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19413,332,1.39 [1.12-1.74],0.0032766519483885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,20015,341,0.94 [0.81-1.08],0.3695826873434221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,16725,292,1.12 [0.93-1.34],0.2183104887582156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,17113,307,1.07 [0.90-1.28],0.4398828550598607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,17155,308,1.65 [1.15-2.36],0.0066181629806363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,17167,307,1.54 [1.17-2.02],0.0023059566162998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,16636,304,1.11 [0.92-1.33],0.2823582816663638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",16725,292,1.20 [1.05-1.36],0.0057166784492899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),16824,303,1.02 [0.96-1.09],0.549002596843231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,19668,335,1.08 [0.88-1.32],0.4734458174860042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,19764,335,1.02 [0.83-1.25],0.8376356412817667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,19064,330,1.29 [1.10-1.52],0.0017990909544743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,16602,297,0.95 [0.79-1.13],0.5327259727319095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,16602,297,1.21 [1.03-1.42],0.0233530021687021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,16735,300,1.04 [0.81-1.35],0.7432827400133548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,17206,307,3.23 [2.19-4.75],2.798817370092727e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,19888,341,1.33 [1.02-1.74],0.0360269795286658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,16628,295,1.11 [0.72-1.72],0.6269221390884259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,19668,335,1.74 [1.23-2.45],0.0018259180110536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,19764,335,1.16 [0.89-1.51],0.2745959308983905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,16735,300,0.97 [0.71-1.35],0.8773840092793252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,16735,300,1.00 [0.86-1.16],0.9668150828770063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,19950,342,1.20 [1.03-1.40],0.0176869596571298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,19668,335,1.85 [1.49-2.31],2.903126467345893e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,17141,308,1.13 [0.87-1.47],0.3546325405576594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,16735,300,0.89 [0.69-1.14],0.3548992365726728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,17199,308,1.11 [0.89-1.38],0.3725269708210769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,17140,308,1.22 [0.97-1.53],0.0848938251807935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,19413,332,0.45 [0.35-0.58],1.3581124435247426e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,16735,300,1.16 [0.89-1.52],0.2683798297768895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,17167,307,0.64 [0.40-1.01],0.0547850644204852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,19301,331,1.04 [0.86-1.24],0.7100704494547212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,16895,301,0.94 [0.79-1.11],0.4511320306850275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,19752,333,1.14 [0.89-1.45],0.3034333062840995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,19752,333,1.00 [0.78-1.30],0.9721335001769198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,19939,343,1.11 [0.95-1.29],0.1850961350343096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,17140,308,0.76 [0.51-1.11],0.1547997101602375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,20015,341,2.54 [1.96-3.29],1.768768626483433e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,19301,331,1.49 [1.27-1.74],6.512098928964297e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,19634,336,2.25 [1.66-3.05],1.717801398686459e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,19413,332,0.87 [0.67-1.14],0.3169538941867261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,17140,308,1.15 [0.89-1.48],0.2885537739648415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,19499,334,0.92 [0.79-1.07],0.2927333474727822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,19635,337,1.31 [1.03-1.67],0.0255299825534977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,19752,333,1.02 [0.78-1.32],0.909512815777722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,19539,332,1.89 [1.39-2.57],5.352939839752168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,19592,336,2.53 [2.01-3.18],2.2001492153687438e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,19301,331,0.94 [0.77-1.15],0.5281703133712343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,19668,335,1.05 [0.93-1.18],0.4189713678376158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,19332,331,1.12 [0.96-1.29],0.1501216640235688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,19680,335,1.31 [0.98-1.75],0.0660703472301178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,19301,331,1.18 [0.98-1.43],0.0876228538066434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,16636,304,1.01 [0.90-1.13],0.8919877969874852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,16735,300,1.10 [0.99-1.22],0.0878189169683562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17206,307,3.74 [2.12-6.62],5.785916912239063e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,16595,297,0.45 [0.31-0.66],3.913292466923591e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,16814,295,0.93 [0.79-1.09],0.377575482616763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,16725,292,1.31 [1.00-1.72],0.0479822186698857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,19529,335,1.18 [0.99-1.40],0.0602157809700702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,19301,331,1.08 [0.84-1.39],0.5393444626491831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,16735,300,0.95 [0.74-1.21],0.6643215198717529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,16895,301,0.98 [0.85-1.13],0.7726379744263203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,19301,331,1.11 [0.90-1.36],0.336369302467625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,17199,308,1.55 [1.14-2.09],0.0045152981827106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,17140,308,1.13 [0.94-1.36],0.198240443344008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",16725,292,1.31 [0.84-2.06],0.2377860008604403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,17199,308,1.12 [0.92-1.36],0.2565178128784686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",16595,297,1.31 [1.05-1.64],0.0164407155030775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,19840,341,1.04 [0.95-1.13],0.4050679182406459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,19829,337,1.66 [1.17-2.35],0.0043765680515434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,16602,297,1.12 [0.95-1.32],0.1931315725848579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,16636,304,1.20 [0.83-1.75],0.3364063315106254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,16602,297,1.13 [0.97-1.32],0.1131135217259429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,17155,308,1.25 [0.99-1.57],0.0586410611852565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,17141,308,1.05 [0.88-1.24],0.6092331760473718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,19752,333,0.97 [0.87-1.07],0.5057571059748417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,19301,331,0.94 [0.85-1.05],0.3042830438204584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,19565,336,1.01 [0.92-1.10],0.8915618206152616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,16595,297,1.05 [0.81-1.36],0.7304941010602246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,19752,333,0.91 [0.73-1.15],0.4536678096679041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,16895,301,0.93 [0.79-1.09],0.349610098705137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,16595,297,0.97 [0.89-1.07],0.5885969986995176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,19332,331,1.01 [0.82-1.24],0.9317889295512418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,19764,335,2.07 [1.41-3.04],0.0002168649883012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",16787,295,0.99 [0.86-1.13],0.8378865642309532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,19565,336,0.63 [0.41-0.96],0.0338005818167466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,19768,339,3.04 [2.22-4.16],4.2933202756498734e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,19556,336,1.34 [0.99-1.80],0.056680699156907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,19301,331,1.08 [0.96-1.21],0.19273821331329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,19332,331,1.04 [0.95-1.15],0.3729363774348624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,20015,341,0.89 [0.74-1.07],0.2049290637342249
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,16974,304,1.16 [1.04-1.29],0.0056811211125208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,19867,338,1.07 [0.79-1.45],0.6677082043862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",17167,307,1.00 [0.76-1.31],0.9954116013207908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,16677,295,1.17 [1.03-1.33],0.0165621900775187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,19664,334,1.32 [1.06-1.64],0.0137757970190621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,17141,308,0.71 [0.44-1.15],0.1594055021378517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,19592,336,1.08 [0.93-1.25],0.3289030204844331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",17124,308,1.04 [0.78-1.37],0.8095027179552234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,19769,335,1.70 [1.45-2.00],8.550862928960055e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,16735,300,1.08 [0.74-1.57],0.6990655688988064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",16725,292,1.18 [1.05-1.34],0.0070373739607422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,19301,331,0.99 [0.86-1.13],0.8649304922179265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,16602,297,0.74 [0.55-1.00],0.0521311478597323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,19740,338,1.33 [1.03-1.72],0.027345269854117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,16602,297,1.07 [0.75-1.53],0.6964776682230056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,19945,340,1.25 [0.77-2.02],0.364415414649313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,17199,308,1.12 [0.77-1.63],0.5382447037857423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,16814,295,0.47 [0.29-0.76],0.0021901900893756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,17141,308,0.96 [0.83-1.12],0.634567642090678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,19764,335,0.75 [0.69-0.82],5.477943377781525e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,19740,338,0.52 [0.36-0.75],0.0005897937110864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,20006,342,1.70 [1.17-2.48],0.0055042181593998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,19776,339,1.05 [0.97-1.14],0.2268114548587165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,19821,335,0.66 [0.40-1.09],0.1055402670578853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,19332,331,0.98 [0.69-1.40],0.9290429614628136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",19752,333,1.18 [1.05-1.33],0.0062559977495278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,19916,343,1.09 [0.91-1.31],0.3308827926757171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,19402,328,1.01 [0.81-1.26],0.913979952821632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,16735,300,1.04 [0.87-1.24],0.6825864767149077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,16814,295,1.61 [1.15-2.24],0.0052445190449332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,20015,341,0.87 [0.68-1.11],0.272189250541449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,19776,339,1.45 [1.18-1.79],0.0005196239545942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,19811,340,0.96 [0.86-1.08],0.4879261255825915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,19752,333,0.96 [0.88-1.05],0.3570493905458333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,19829,337,0.75 [0.57-0.99],0.0428640561700063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,16735,300,1.05 [0.89-1.24],0.5613475765173361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,19752,333,1.20 [1.09-1.31],9.294746876687975e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,19735,338,1.06 [0.92-1.24],0.4083175367881518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,19413,332,1.47 [1.22-1.76],3.844103857459701e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,17140,308,1.03 [0.93-1.15],0.5642480007313957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,17155,308,1.02 [0.90-1.16],0.7020329288549252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,19592,336,1.01 [0.91-1.12],0.8706040095800592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,16677,295,1.01 [0.76-1.35],0.942332685146786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,16595,297,1.14 [0.97-1.34],0.1008289082043574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,19752,333,1.07 [0.95-1.19],0.2499855067026789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,19668,335,1.19 [1.06-1.35],0.0045752757327079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,19100,320,1.27 [1.12-1.43],0.0001160129609799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,19700,337,1.39 [1.18-1.63],8.620619015179925e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,19805,340,2.05 [1.75-2.40],6.575690723799042e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,19332,331,1.39 [1.00-1.93],0.0490161301767078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,17199,308,0.95 [0.75-1.21],0.6871004761935472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,19776,339,1.11 [0.91-1.35],0.3056295371230307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,19374,327,2.15 [1.73-2.66],3.502007639419341e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,19917,341,1.50 [1.33-1.70],7.651542868933229e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,19748,339,1.64 [1.40-1.93],1.8840405907962072e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",16602,297,1.04 [0.82-1.32],0.7515849634235144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,16735,300,0.88 [0.70-1.11],0.2715989880561474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,16895,301,0.89 [0.67-1.18],0.4090098862055649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,19735,334,1.07 [0.98-1.18],0.1399543550574782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,16814,295,1.10 [0.92-1.30],0.2907917508466215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,19939,343,0.69 [0.52-0.92],0.0117624295332727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,17155,308,1.15 [0.76-1.72],0.5111751544025176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,16895,301,0.97 [0.72-1.30],0.8236827830197733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,16595,297,0.96 [0.68-1.34],0.7964824275602371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,16595,297,0.89 [0.76-1.05],0.1615829191738284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,19402,328,0.99 [0.86-1.13],0.8522501860806537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,19668,335,1.02 [0.91-1.15],0.7258786526851395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,19811,340,1.05 [0.92-1.20],0.5109734478304986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,19776,339,1.40 [1.15-1.70],0.0007111642131001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,17111,307,1.07 [0.83-1.39],0.5798561280068041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,17214,308,4.79 [3.37-6.80],2.0798598079442494e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,16735,300,0.90 [0.76-1.07],0.2502956864432224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",16602,297,0.89 [0.64-1.25],0.5157310297086743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",17167,307,0.81 [0.55-1.18],0.272050427117693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",19332,331,1.48 [1.07-2.05],0.0181534870872711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",16557,296,1.01 [0.65-1.57],0.9650855567411832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",17167,307,1.22 [1.06-1.40],0.0055307612707726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",16677,295,0.93 [0.59-1.48],0.7698936751704316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,19633,335,1.60 [1.39-1.83],4.188532676994738e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,16735,300,1.34 [1.01-1.77],0.0415212719189245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,19748,337,1.03 [0.89-1.18],0.7241366192122012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,19950,342,2.13 [1.75-2.59],3.8668935347852864e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,19829,337,1.01 [0.88-1.16],0.8883422537703007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,16965,305,1.10 [0.91-1.32],0.3296024026432289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,19402,328,0.58 [0.48-0.69],2.15453762124537e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,16677,295,1.07 [0.95-1.21],0.274447534036349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",17155,308,1.71 [1.18-2.48],0.0042629330459663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,16895,301,1.02 [0.92-1.13],0.6741454675683672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",17141,308,1.17 [1.03-1.33],0.0131635112131003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,19402,328,0.85 [0.61-1.19],0.3560464918558607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,16602,297,0.93 [0.77-1.12],0.4435895254329289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,17141,308,0.98 [0.89-1.09],0.7198597053591687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,17140,308,1.07 [0.95-1.20],0.2540892890269686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,16895,301,1.28 [1.06-1.53],0.0089901698490364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,19332,331,1.29 [1.08-1.54],0.0053950491459549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,19668,335,1.00 [0.94-1.05],0.8639714989523741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,17201,308,0.98 [0.86-1.11],0.7302924120987113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,16595,297,1.06 [0.82-1.37],0.6578636359093055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,19413,332,1.37 [1.23-1.53],2.4224859938061386e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,16814,295,0.93 [0.63-1.36],0.7073321528581374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",17199,308,0.99 [0.85-1.15],0.8702527124918846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",16725,292,0.99 [0.86-1.13],0.8416346717802896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,17167,307,1.10 [0.93-1.30],0.278640786982424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,17199,308,1.11 [1.00-1.25],0.0600981601502322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,16602,297,1.01 [0.77-1.31],0.9505983398129132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,16595,297,1.35 [1.06-1.71],0.016233893846399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,17201,308,1.04 [0.94-1.15],0.3961102127635311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",16602,297,0.91 [0.67-1.24],0.5556059156987052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,16725,292,0.84 [0.72-0.98],0.0271171538946076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,16725,292,1.04 [0.84-1.28],0.7049583866982796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,16735,300,1.09 [0.97-1.23],0.1412048521108565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",16735,300,1.13 [0.93-1.37],0.2176283831724519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,17167,307,1.13 [0.83-1.53],0.4378340947405317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,19413,332,1.04 [0.89-1.21],0.6556546040320487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,19776,339,1.11 [0.89-1.38],0.3628827318127552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,16636,304,1.07 [0.85-1.35],0.576005646775814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,16602,297,0.91 [0.73-1.15],0.4362157939495799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,16814,295,0.91 [0.81-1.03],0.1467950830471686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,19797,340,2.02 [1.70-2.40],1.0630808657066797e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,19301,331,0.96 [0.78-1.18],0.7096588058578757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,16602,297,1.19 [0.94-1.49],0.1456324346921699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,16735,300,0.98 [0.89-1.07],0.6365960593921394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,19502,331,0.91 [0.76-1.08],0.2607141287419641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,17140,308,1.11 [0.91-1.36],0.3049655325709286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,19764,335,1.11 [0.94-1.31],0.2070731696727095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,16650,294,0.89 [0.70-1.14],0.3557162381927078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,16696,292,0.93 [0.76-1.14],0.475089434135727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,16814,295,2.06 [1.22-3.47],0.006669043941164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,19301,331,1.19 [1.01-1.39],0.0370802619229942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,17103,307,1.00 [0.75-1.34],0.9860595834491478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,17155,308,0.91 [0.64-1.29],0.5907352710838383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",17167,307,0.97 [0.76-1.25],0.8417262483647426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,19829,337,1.98 [1.40-2.80],0.0001086542072761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,19413,332,0.99 [0.83-1.19],0.9422591544064678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,19867,338,0.71 [0.52-0.96],0.0277769527722028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,19776,339,1.27 [0.88-1.83],0.2008142487715531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,19950,342,0.57 [0.44-0.74],1.3979202387640207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,19709,332,1.16 [1.04-1.29],0.006282701812982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,19840,341,0.99 [0.90-1.09],0.8696205811345812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,19413,332,0.95 [0.76-1.19],0.6641782196830641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,19723,333,0.93 [0.71-1.21],0.5729231736486031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17141,308,1.77 [1.33-2.36],0.0001022463449599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,19939,343,1.11 [0.79-1.55],0.5649388224216954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,19332,331,1.11 [0.96-1.27],0.1470342022885585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,17140,308,0.98 [0.81-1.20],0.8733019645817981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,16651,293,1.10 [0.79-1.53],0.5744090573722793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,17141,308,1.00 [0.88-1.13],0.9700690251279102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",19301,331,1.12 [0.99-1.25],0.0610592761507658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,16602,297,1.31 [1.01-1.69],0.0442666387246933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,16602,297,1.13 [0.96-1.33],0.1325017671214017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,16677,295,1.01 [0.69-1.48],0.9609324146132578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,19737,335,2.13 [1.60-2.83],2.444461839438495e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,19829,337,1.68 [1.30-2.18],8.735731707284259e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,16677,295,1.04 [0.81-1.34],0.7546803036738061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,16677,295,0.95 [0.67-1.35],0.7748356169825983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,19277,329,1.58 [1.31-1.92],2.961505392156977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,16895,301,0.92 [0.77-1.10],0.3815591530029457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,19829,337,0.90 [0.71-1.13],0.3605139624402886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,19840,341,1.24 [0.89-1.72],0.2033191225819655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,17140,308,1.03 [0.93-1.14],0.603247009983953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,17167,307,0.99 [0.59-1.64],0.9588116894322118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,17214,308,1.05 [0.89-1.24],0.5372064969920253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,20006,342,2.08 [1.52-2.83],3.874163204553916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,16677,295,1.12 [0.98-1.28],0.1053065728344126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",19752,333,0.93 [0.84-1.03],0.1734992746254885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19413,332,1.52 [1.32-1.76],9.489439244271609e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,16725,292,1.00 [0.85-1.17],0.9648406304953704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,17167,307,1.07 [0.84-1.37],0.569391831929272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,16602,297,1.09 [0.93-1.28],0.2720718801478309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,16895,301,1.14 [0.95-1.37],0.1603415896511429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,19301,331,1.06 [0.87-1.30],0.5556213702701953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",17141,308,1.14 [1.03-1.28],0.0140040344987139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,16602,297,0.96 [0.80-1.15],0.6466866404058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,16602,297,1.09 [0.82-1.45],0.5482373189372866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,19592,336,1.83 [0.82-4.10],0.1389402470433932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,17199,308,1.20 [0.86-1.69],0.2803008344398076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,17155,308,1.41 [0.86-2.32],0.1749486959253852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,16419,291,2.74 [1.91-3.94],4.719833083743723e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,19802,337,1.37 [1.05-1.79],0.0199141602617594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,19776,339,1.13 [0.99-1.29],0.0796443267148857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,19301,331,1.09 [0.91-1.30],0.3536760539149173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,16725,292,0.72 [0.55-0.93],0.0128531094839805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,17132,305,1.08 [0.92-1.26],0.3448212123228292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,16735,300,1.04 [0.88-1.23],0.6756305614325443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,16636,304,1.23 [0.97-1.54],0.0821963459479041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,16677,295,1.17 [0.68-2.04],0.5726504771077398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,19768,339,2.54 [1.83-3.53],2.8365528324155825e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,17069,306,1.19 [1.02-1.39],0.0241158542189098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,19592,336,1.02 [0.89-1.16],0.7937470573031246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,16595,297,1.05 [0.78-1.40],0.7578755483529394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,17167,307,1.06 [0.89-1.26],0.5203742984507471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,19776,339,1.00 [0.66-1.52],0.9927141260493584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,16602,297,1.00 [0.89-1.13],0.9569104464300846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",19332,331,1.07 [0.90-1.28],0.4276987173515082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",16602,297,1.09 [0.82-1.43],0.5584796026462555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",19332,331,1.44 [1.23-1.69],4.329944485428329e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,20015,341,0.81 [0.44-1.49],0.4989493727589319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,17201,308,1.26 [0.77-2.05],0.3555228503801956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,20015,341,1.55 [1.18-2.04],0.0016510503226259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,16910,302,2.41 [1.86-3.11],1.558122005601016e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,19764,335,1.70 [1.32-2.19],4.400689056327498e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,16677,295,1.26 [0.90-1.75],0.180443902121929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,16677,295,0.93 [0.82-1.04],0.2138975871502821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,17199,308,1.40 [1.11-1.76],0.0044252711335618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,19402,328,1.12 [1.04-1.21],0.003419089096298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,19752,333,1.15 [0.96-1.37],0.1227132316156583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,16602,297,0.94 [0.68-1.29],0.6879108662749123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,19301,331,1.03 [0.91-1.17],0.6020706057608824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,19776,339,1.62 [1.30-2.00],1.0673626641292144e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,17201,308,1.79 [1.29-2.49],0.0005111544680401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,19764,335,0.64 [0.47-0.87],0.0039825339191468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,19939,343,0.78 [0.67-0.90],0.0007920407950308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,19764,335,0.98 [0.70-1.37],0.890881984782224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,17214,308,1.04 [0.92-1.17],0.5746004427067434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,17167,307,1.36 [1.07-1.72],0.0118585769604949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,19900,338,2.58 [1.82-3.67],1.2100374481755725e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,19776,339,1.47 [1.05-2.05],0.0251334009218157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,19413,332,1.05 [0.86-1.27],0.65476575192717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,16735,300,0.89 [0.62-1.29],0.5539443431892813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,19950,342,1.07 [0.91-1.25],0.4203358309964613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",17199,308,1.03 [0.89-1.20],0.6627707799922399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,17155,308,2.19 [1.69-2.85],3.4334052524887393e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,19717,331,0.91 [0.81-1.02],0.0988597355389181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,19829,337,1.30 [1.09-1.55],0.0039130659322628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,19752,333,1.29 [0.98-1.69],0.0643659144912798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,19301,331,1.06 [0.83-1.36],0.6438418594672639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,19764,335,0.68 [0.46-1.01],0.0559133009417137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,19950,342,0.52 [0.33-0.81],0.0041454743660981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,19764,335,1.27 [1.17-1.38],3.366177274494053e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,19752,333,0.97 [0.86-1.09],0.5853688038918323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,17140,308,1.07 [0.94-1.20],0.3130313360796136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,19909,343,1.31 [1.02-1.69],0.0357191804118389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,20006,342,1.04 [0.89-1.22],0.6176326293846317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,16725,292,1.05 [0.64-1.73],0.851058488971038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,16602,297,0.99 [0.78-1.26],0.959326061821231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,17111,307,1.16 [1.02-1.32],0.020488325215796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],19668,335,0.84 [0.70-1.01],0.0657434883043162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,19776,339,1.27 [1.05-1.55],0.0162286188632537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,16677,295,1.01 [0.88-1.16],0.8963739139497698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,16602,297,1.02 [0.69-1.51],0.9072909368202012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,16602,297,1.16 [0.81-1.66],0.4196911493770793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,19332,331,0.90 [0.69-1.17],0.416405738677495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,16677,295,1.04 [0.71-1.52],0.8453892658631273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,19527,336,0.78 [0.66-0.93],0.0059726919434623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,17167,307,2.37 [1.95-2.89],9.10708278202218e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,19300,328,0.76 [0.62-0.93],0.0071502574456229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,16895,301,1.09 [0.91-1.29],0.3477210780391734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,17141,308,1.06 [0.90-1.24],0.5073468878034211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,19668,335,0.86 [0.63-1.18],0.3503560988421937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,19776,339,1.34 [1.07-1.67],0.0096485082175798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,16895,301,0.90 [0.73-1.11],0.3153705462770733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,16203,287,1.21 [1.10-1.33],0.0001436049728961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,19565,332,1.38 [1.20-1.59],5.348867141770778e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,19840,341,0.82 [0.66-1.03],0.095116297534998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,19668,335,0.71 [0.61-0.82],2.6582755755569627e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,16636,304,0.95 [0.74-1.23],0.6931580652058669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,17155,308,1.04 [0.94-1.16],0.4251055213770363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,16725,292,1.09 [0.92-1.29],0.3219096877337924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,19668,335,1.07 [0.86-1.33],0.5580659185675544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,17145,307,2.82 [1.68-4.76],9.75278841441618e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,17155,308,1.19 [0.91-1.55],0.2107406360625144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,19768,339,2.80 [2.09-3.74],3.1898361486779047e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,19652,331,1.54 [1.34-1.76],4.6035144423234924e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,19900,338,6.25 [3.91-10.01],2.1637529532878075e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,16735,300,1.06 [0.82-1.37],0.6704728101480069
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,16636,304,1.11 [0.91-1.36],0.3138587310476951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,17141,308,1.06 [0.87-1.29],0.5369686801525735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,17167,307,1.19 [1.00-1.43],0.0517762265858423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",16725,292,1.15 [0.98-1.35],0.0804130186160936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,19950,342,1.08 [1.01-1.16],0.0210789464955905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,19682,334,1.44 [1.12-1.84],0.004762308453212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,16602,297,1.02 [0.84-1.23],0.8414165882372072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,19413,332,1.01 [0.85-1.21],0.8965291367909888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,19300,328,0.93 [0.81-1.07],0.3266147780772719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,19592,336,1.01 [0.91-1.11],0.8810954035861777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,17167,307,1.02 [0.92-1.14],0.6900786371809957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",16895,301,1.02 [0.80-1.30],0.8788430698817922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19402,328,1.16 [0.98-1.37],0.0841071980579944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,16725,292,0.84 [0.63-1.11],0.2141663487540043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,16568,296,0.85 [0.67-1.09],0.2011440833750599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,19332,331,0.97 [0.82-1.14],0.6960421190271726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,16677,295,1.14 [0.85-1.52],0.3743242707940781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,17045,306,1.07 [0.75-1.52],0.7065168252131013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,17155,308,2.23 [1.76-2.82],1.900324309996861e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,16602,297,1.06 [0.90-1.26],0.4768954348084409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,19938,341,1.17 [0.82-1.67],0.3941175542047234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,19776,339,0.71 [0.49-1.02],0.0623222085863558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,19413,332,1.00 [0.80-1.23],0.9643361791360338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,16895,301,1.08 [0.94-1.25],0.2827652463499757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,19776,339,1.11 [0.91-1.35],0.3087709378625718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,19752,333,1.12 [0.97-1.30],0.128666198356246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,16814,295,1.11 [0.87-1.42],0.4143998916102644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,16595,297,0.96 [0.66-1.39],0.8188698597201247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,19332,331,0.90 [0.74-1.10],0.3050622506433753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,17141,308,0.79 [0.53-1.18],0.2538261481758065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,16636,304,1.04 [0.91-1.18],0.5900933802458799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,16782,295,1.16 [0.93-1.45],0.1967118076631644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,17167,307,1.03 [0.88-1.21],0.6838524083070846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,19941,341,0.83 [0.51-1.35],0.4525483226081027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,17167,307,1.82 [1.16-2.83],0.0084287443097477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,19764,335,1.16 [0.90-1.50],0.2523188198931996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,17141,308,0.78 [0.54-1.12],0.1839118852373442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,17141,308,0.77 [0.55-1.06],0.1043193975261318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,17140,308,1.40 [1.06-1.84],0.0183655730939872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,16595,297,1.09 [0.93-1.28],0.2776174349945377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,17140,308,0.96 [0.74-1.24],0.756294006070187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,20015,341,1.67 [1.31-2.13],3.543496611660687e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,17141,308,1.12 [0.96-1.30],0.138238804570835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,17199,308,1.03 [0.92-1.16],0.6180395381846613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,19903,340,1.24 [0.99-1.55],0.0649935960422855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,19668,335,1.52 [1.11-2.07],0.0081604554658782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,19950,342,1.22 [1.03-1.44],0.0216405441949847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,19764,335,1.08 [0.93-1.25],0.3348305356461205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,16595,297,0.98 [0.77-1.24],0.852940226777888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",16595,297,1.07 [0.86-1.33],0.5523049853324422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",16602,297,1.06 [0.88-1.28],0.5320545048731318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",16814,295,0.96 [0.86-1.08],0.5147083921186058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,20015,341,1.09 [0.95-1.25],0.2309575776086014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,19840,341,1.12 [1.00-1.25],0.0567413080000229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,19301,331,1.24 [0.87-1.78],0.2400041627002853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,19764,335,1.40 [1.00-1.96],0.0476224772727556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,20015,341,0.90 [0.68-1.19],0.4580681723502474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,16595,297,0.96 [0.70-1.30],0.7687276744787354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,16814,295,1.54 [0.97-2.44],0.0662813689501218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,17201,308,1.18 [0.99-1.41],0.0712431528132971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,16595,297,0.95 [0.78-1.17],0.6516323094058776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,17167,307,1.02 [0.92-1.12],0.7398319738814527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,19840,341,1.00 [0.92-1.08],0.9832390241639056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",19301,331,1.08 [0.88-1.32],0.4704082316338899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,16735,300,1.00 [0.79-1.27],0.9897069113393034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,16595,297,1.21 [1.02-1.42],0.0250970896576295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,16602,297,1.25 [1.04-1.50],0.0166536596338102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,16677,295,1.56 [1.26-1.92],3.571131316797085e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,20015,341,1.15 [0.74-1.78],0.5293107093224241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,19776,339,1.16 [0.98-1.38],0.0893548059155808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,19776,339,1.67 [1.21-2.30],0.0016931307161625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,16725,292,1.06 [0.72-1.57],0.7697862975890151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,16814,295,1.30 [0.93-1.82],0.1252466888270741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,17214,308,1.21 [0.80-1.83],0.3727341554383148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,16677,295,1.11 [1.01-1.21],0.0324337500556071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,17068,305,1.09 [0.97-1.23],0.137896604520075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,19332,331,1.01 [0.84-1.23],0.8885238097904549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,16595,297,1.05 [0.83-1.31],0.7026151490127448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,16735,300,1.04 [0.87-1.24],0.6767831635886759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",19640,333,0.97 [0.85-1.10],0.6053808822658733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,17214,308,1.40 [1.20-1.62],1.37121690775158e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",17199,308,1.14 [0.92-1.40],0.2223591097340888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,20006,342,2.18 [1.58-3.01],2.151989404465113e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,19918,340,1.35 [1.09-1.67],0.0056759054759425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,16997,304,1.10 [0.74-1.63],0.6409300220565584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,16602,297,1.09 [0.90-1.31],0.3785681148492174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,16735,300,1.12 [0.93-1.36],0.2311950217512193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,16677,295,0.93 [0.81-1.07],0.3044452221212119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,17167,307,1.05 [0.95-1.16],0.3375038901680259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,17141,308,1.40 [1.14-1.72],0.0013521433415147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,16595,297,0.94 [0.82-1.08],0.3807453294358769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,19592,336,0.92 [0.65-1.30],0.630091295518004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,16814,295,1.11 [0.85-1.45],0.4245903787855615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,17214,308,0.90 [0.56-1.44],0.6519867196855624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,19516,337,1.57 [1.34-1.83],1.3562195777901564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",17167,307,1.03 [0.89-1.20],0.6476907364474422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,19515,335,4.03 [3.22-5.03],1.4444769626587914e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,19752,333,1.19 [1.02-1.40],0.0276681014550083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,19776,339,1.56 [1.14-2.14],0.0059593091249553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,16677,295,1.13 [0.94-1.37],0.2006723556721238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,19776,339,2.15 [1.71-2.72],8.753393189281129e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,19764,335,1.59 [1.33-1.92],6.866448239580579e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,16814,295,1.05 [0.89-1.25],0.5334392708982987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,16568,296,0.98 [0.84-1.15],0.8091542622315453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,17199,308,2.67 [1.78-4.02],2.160966307926063e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,16602,297,1.17 [0.97-1.41],0.1032522795727147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,19774,339,1.14 [0.98-1.32],0.093346575203233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,16895,301,1.08 [0.93-1.26],0.3038748542838712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,19592,336,1.20 [1.01-1.43],0.0378213675178247
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,19829,337,4.84 [3.53-6.64],1.7236733303786726e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,19987,341,0.61 [0.50-0.76],4.654890859859306e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",19744,337,1.43 [1.23-1.65],1.3395359364239895e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,19840,341,1.03 [0.92-1.15],0.6605301547523574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,19776,339,0.45 [0.33-0.60],6.902079692256247e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,19945,340,1.66 [1.38-2.00],1.0924168519068157e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,19776,339,2.48 [1.91-3.23],1.2897430447525354e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,19605,336,5.50 [4.17-7.26],2.044506624689985e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",17155,308,0.88 [0.73-1.07],0.1949738026049462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",16677,295,1.22 [0.96-1.56],0.1035283804170269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",17155,308,1.06 [0.95-1.19],0.3148179296781666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,17155,308,1.09 [0.93-1.29],0.2811389138186972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,16784,300,2.23 [1.35-3.66],0.0015882625216165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,19332,331,1.20 [0.90-1.58],0.2113558147403686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,19764,335,1.13 [0.90-1.42],0.3080822294247916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,19764,335,1.10 [0.95-1.27],0.2127670504546841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,17118,308,1.22 [1.00-1.48],0.0512903521253376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,19961,341,1.31 [1.01-1.69],0.0413094040983737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,19301,331,0.53 [0.36-0.78],0.0013010642298054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,17155,308,1.67 [1.16-2.41],0.0059464599764466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,19752,333,1.02 [0.90-1.16],0.7412744406431394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,19913,340,2.40 [1.66-3.48],3.7921670269599487e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,19699,333,0.89 [0.72-1.11],0.3005135022379719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,19676,333,1.02 [0.97-1.08],0.4977091187976564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,16602,297,0.96 [0.82-1.12],0.5793443341480997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,16602,297,1.06 [0.87-1.28],0.5860372597491619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,16735,300,1.35 [1.10-1.67],0.0040361462556541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,19301,331,1.01 [0.92-1.11],0.8745658529545146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,17214,308,0.82 [0.70-0.97],0.0206077655466026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,17155,308,0.90 [0.78-1.02],0.1070634995077973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,19740,338,0.98 [0.95-1.01],0.2019960485167081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,16725,292,0.96 [0.79-1.18],0.7231936134140204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,16636,304,0.81 [0.60-1.08],0.1433321878294499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",19413,332,1.10 [1.01-1.20],0.0256385661313539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,19668,335,0.98 [0.50-1.91],0.9521610654040324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,19829,337,0.73 [0.52-1.04],0.079272638890553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,16677,295,1.51 [1.19-1.91],0.0006341250958149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,16677,295,0.88 [0.58-1.33],0.5329715279631622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",19668,335,1.33 [1.05-1.66],0.0156978492101231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,16725,292,0.80 [0.68-0.94],0.0059859432865824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,17214,308,0.78 [0.53-1.15],0.2150196402714943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,19402,328,1.55 [1.17-2.06],0.0025651959154637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,19840,341,0.71 [0.54-0.93],0.0134691609798332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,17201,308,1.12 [0.83-1.51],0.4622042163386115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,17068,305,1.03 [0.90-1.18],0.6753179993418683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,19950,342,1.18 [0.96-1.46],0.1253435879393717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,19789,338,1.04 [0.94-1.16],0.4529490841321123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,16895,301,1.13 [0.96-1.32],0.1570328601414868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",17201,308,1.22 [1.03-1.44],0.0193356231980366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,16677,295,1.34 [0.95-1.88],0.0944024132545498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,19301,331,0.86 [0.60-1.22],0.3993729989478445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,16677,295,0.88 [0.70-1.11],0.2834913405366694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,17199,308,1.00 [0.81-1.24],0.9674516822075938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,19668,335,1.10 [0.92-1.31],0.2829753454755547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,17140,308,0.93 [0.81-1.07],0.3304144542283278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,19829,337,1.08 [0.97-1.20],0.1487187483164332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,16895,301,1.04 [0.89-1.23],0.5989524439325608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,17167,307,1.08 [0.93-1.25],0.3136082008720963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17167,307,1.54 [1.20-1.98],0.0007593814517009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,19764,335,1.01 [0.89-1.15],0.8742290284158947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,20006,342,1.03 [0.92-1.14],0.6135871083788628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,17141,308,1.03 [0.94-1.13],0.5786318050251783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,19592,336,1.13 [0.89-1.44],0.3229029374811931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,16735,300,1.12 [0.98-1.28],0.091646730010909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,19717,335,0.93 [0.84-1.02],0.123787534277594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,19301,331,0.97 [0.80-1.16],0.7170186202987002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,16595,297,1.07 [0.68-1.69],0.7684576660792948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,17201,308,1.99 [1.48-2.69],6.0506797587078985e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,17140,308,1.25 [1.01-1.56],0.0414879433962731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,19896,340,1.56 [1.15-2.11],0.0038083634258852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,19185,328,1.02 [0.91-1.14],0.7350425163627318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,16927,306,0.94 [0.78-1.14],0.5305743065763826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19413,332,1.24 [1.08-1.42],0.0016868465345067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",20006,342,0.96 [0.82-1.12],0.5902460117845816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,19939,343,0.86 [0.73-1.01],0.0722434405957739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,19413,332,1.41 [1.01-1.95],0.0425215677960724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,19740,338,1.19 [0.77-1.85],0.4349008020276019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,17201,308,1.45 [1.17-1.79],0.0006764156671863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,17201,308,1.40 [1.12-1.76],0.0032121351487489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,19413,332,0.98 [0.81-1.18],0.8248082943710611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,16735,300,1.05 [0.71-1.55],0.7990813172850395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,19764,335,1.08 [0.96-1.23],0.1925975005290281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,17119,308,1.03 [0.89-1.20],0.6532721940982099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,19413,332,1.14 [0.90-1.43],0.2838692095400471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,16602,297,0.89 [0.66-1.20],0.4532350816407963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,16814,295,1.03 [0.94-1.13],0.5860678064545108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,19301,331,0.98 [0.84-1.14],0.7515482713957252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,19950,342,1.12 [0.98-1.28],0.0929121017729852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,17155,308,1.49 [1.21-1.83],0.0001771651914124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,19837,338,0.56 [0.39-0.82],0.0025600335730551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,16602,297,1.07 [0.78-1.46],0.6735429883944757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,19752,333,0.79 [0.64-0.97],0.0249479267157103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,17206,307,1.09 [0.70-1.70],0.7017833673171311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,16688,294,1.00 [0.85-1.18],0.9695101324015116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,16677,295,0.97 [0.75-1.26],0.8326577115077989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,16725,292,1.08 [0.80-1.45],0.6253516032399332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,19867,338,1.22 [1.04-1.44],0.0153029155095394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,16677,295,2.19 [1.74-2.76],3.919618477725466e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,19695,334,0.89 [0.69-1.14],0.3531127282884317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,17155,308,1.54 [1.15-2.05],0.0032698849813819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,19670,339,2.80 [2.27-3.45],5.084145145421796e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,19332,331,0.95 [0.87-1.05],0.3103830747011245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,19939,343,2.63 [1.87-3.71],3.2064899065084834e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,19286,327,1.20 [1.00-1.44],0.0496966576491446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,16895,301,1.42 [1.01-2.00],0.0452942221985262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,17043,304,2.76 [2.02-3.76],1.5526812914807176e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,17141,308,1.00 [0.80-1.25],0.9867171200332924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,17141,308,1.02 [0.98-1.07],0.3710118350365277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,19592,336,1.21 [1.10-1.34],0.0001502138080856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,19752,333,1.02 [0.88-1.19],0.762343464350149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,19301,331,1.13 [0.92-1.40],0.2481795075848578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,16595,297,0.97 [0.64-1.46],0.8820260302842912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,17167,307,0.95 [0.75-1.20],0.6683067098562916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,16735,300,0.98 [0.78-1.23],0.8523652358712669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,19668,335,1.04 [0.87-1.24],0.6356345455064571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,19560,336,1.10 [0.84-1.45],0.4888584251929162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,19510,336,1.12 [0.85-1.49],0.4262495897980332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,19752,333,1.12 [0.92-1.37],0.2619742680209084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,16677,295,1.08 [0.88-1.32],0.4891722009779492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,19752,333,1.11 [0.98-1.24],0.0968152422767331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,19301,331,1.22 [1.03-1.43],0.0203683930279351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,16227,283,0.99 [0.89-1.11],0.9062867296599262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",19332,331,1.07 [0.76-1.51],0.6938593461899116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,19633,334,1.30 [0.97-1.76],0.0815174748622006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,16562,289,1.22 [0.98-1.50],0.0732779430552532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,17199,308,1.14 [1.00-1.30],0.0445797181434504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,16735,300,1.01 [0.88-1.16],0.8571631216644346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,19752,333,1.25 [0.99-1.59],0.0631852576388804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,19332,331,1.86 [1.42-2.44],7.79558890791336e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,19402,328,1.77 [1.48-2.13],9.956655489890434e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,16677,295,1.29 [1.04-1.59],0.0191537941550742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,19592,336,1.10 [0.97-1.25],0.1411105230006115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,19811,340,1.00 [0.90-1.12],0.956485497822208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,16651,295,1.06 [0.79-1.43],0.6875008855219013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,17199,308,1.71 [1.19-2.46],0.0036488863124765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,17201,308,1.95 [1.23-3.08],0.0042844159356402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,20015,341,0.79 [0.55-1.12],0.177874738863366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,17141,308,1.00 [0.80-1.25],0.9727551828642368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17141,308,2.32 [1.53-3.53],7.814193917739037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,19722,331,1.16 [0.77-1.75],0.4841860184992578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,19531,335,0.84 [0.62-1.13],0.2484895427324863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,17155,308,0.67 [0.50-0.90],0.0079149836644592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,20015,341,0.64 [0.43-0.95],0.0275726505557138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,17199,308,1.80 [1.26-2.57],0.0011870012877213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,16814,295,0.91 [0.74-1.10],0.3295584267862876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,19235,327,1.22 [1.02-1.45],0.0252686327885767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,16895,301,0.92 [0.69-1.23],0.5681312503050204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,19752,333,1.55 [1.23-1.95],0.0001682224942819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,19858,339,0.96 [0.88-1.05],0.360713865346281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,19950,342,2.31 [1.85-2.89],1.2041998795319733e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,17140,308,1.10 [0.93-1.31],0.2610234559912928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,19332,331,1.08 [0.89-1.31],0.4558626721257282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,16725,292,0.82 [0.60-1.12],0.2042565814144638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,16602,297,1.06 [0.94-1.18],0.3523695720002879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,17206,307,1.02 [0.73-1.42],0.9132946186418764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,19662,334,1.24 [0.98-1.57],0.0791089384458268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,19788,339,1.76 [1.23-2.53],0.00211526380353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,16874,303,1.47 [1.20-1.80],0.0002139071390908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,17199,308,1.09 [0.89-1.34],0.412704595035498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,17199,308,1.00 [0.90-1.12],0.93811208183123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,17199,308,1.06 [0.92-1.22],0.3927368988205232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,17140,308,1.01 [0.83-1.21],0.9552038333581612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,16602,297,0.98 [0.82-1.17],0.84426039624629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,19413,332,1.08 [0.96-1.22],0.2067774677359682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,16602,297,0.97 [0.85-1.12],0.7144734861946025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,16636,304,0.84 [0.67-1.06],0.1524130474789082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,17140,308,1.11 [0.89-1.37],0.3518165061429501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,19752,333,0.68 [0.54-0.85],0.000717653264275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,19332,331,1.22 [1.01-1.49],0.043915877894428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,16814,295,1.00 [0.86-1.17],0.9864244346314828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,19301,331,1.26 [1.07-1.49],0.0046266781489398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,19413,332,1.12 [0.95-1.31],0.1905966631186765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,16735,300,1.01 [0.85-1.20],0.9500314125012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,19301,331,1.08 [0.86-1.35],0.5120966668325226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,16895,301,1.19 [0.99-1.42],0.060985320215685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,16677,295,1.28 [0.86-1.90],0.2292041258118049
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,17140,308,1.05 [0.84-1.31],0.6570192139381392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,16725,292,0.94 [0.75-1.19],0.6255234391233992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,16636,304,0.97 [0.67-1.41],0.8834677995786415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,19301,331,0.94 [0.75-1.19],0.6328407179185007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,16677,295,0.94 [0.78-1.12],0.4694955091556092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,16895,301,0.94 [0.75-1.17],0.5701084574298129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,19301,331,1.13 [0.84-1.53],0.428240443712506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,19900,338,1.42 [1.18-1.70],0.0001417791223178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,19332,331,1.21 [0.90-1.63],0.2111505345170979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,16595,297,0.93 [0.71-1.23],0.6076002116310977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,19301,331,1.17 [1.01-1.36],0.0336382013720358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,17167,307,1.79 [1.44-2.21],9.161890711504173e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,19309,329,1.26 [1.03-1.54],0.0252601548772722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,17167,307,1.01 [0.88-1.17],0.8805153372447384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,16602,297,0.98 [0.76-1.25],0.848230622427315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,16595,297,1.01 [0.77-1.32],0.9489240090283952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,16735,300,0.96 [0.79-1.16],0.6479311229328615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,19668,335,1.33 [1.18-1.50],5.063350143095426e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,19668,335,1.27 [1.07-1.49],0.0056533913048632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,17141,308,1.31 [1.13-1.53],0.0004705807401915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,16677,295,0.98 [0.81-1.19],0.8370541725558316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,16725,292,1.03 [0.92-1.16],0.5834619752687067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,17140,308,1.09 [0.87-1.35],0.4531186975541666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,19402,328,1.02 [0.81-1.29],0.870876260847198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,16725,292,1.66 [0.95-2.88],0.0735744599562722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,17167,307,1.12 [0.94-1.35],0.2052489818348704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,19671,336,1.35 [1.13-1.62],0.0010276632265735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,20015,341,1.19 [1.01-1.40],0.0335611794036245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,20015,341,1.26 [1.09-1.45],0.001495733818577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,17140,308,0.77 [0.56-1.04],0.0928936735365867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,19768,339,1.38 [1.15-1.67],0.0005958980936698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,16677,295,1.45 [1.20-1.76],0.0001372417251172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,19776,339,1.40 [1.02-1.92],0.0360353757588678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,19764,335,1.48 [1.33-1.65],3.847903391065256e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,16677,295,1.20 [0.90-1.59],0.220859046636529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,16595,297,0.90 [0.63-1.28],0.5586294091387876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,19668,335,0.63 [0.48-0.82],0.0006001950997754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,19730,335,1.28 [1.04-1.59],0.0211923444943702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",16602,297,0.94 [0.71-1.22],0.6257767453119223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,17140,308,1.27 [0.78-2.06],0.3361313172443849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,17167,307,1.00 [0.86-1.17],0.9584274102608588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,16895,301,0.98 [0.80-1.19],0.8022478074119788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,19950,342,0.66 [0.49-0.91],0.010274591281854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,19950,342,0.90 [0.63-1.29],0.5708736114173993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,17167,307,1.02 [0.85-1.23],0.8306642184290931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,19413,332,1.01 [0.86-1.18],0.9154201626104428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,19495,334,1.03 [0.95-1.13],0.4516714224893254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,16677,295,1.06 [0.83-1.35],0.6371830213410858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,16814,295,1.11 [0.89-1.38],0.358412989486935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,19888,341,1.12 [0.95-1.32],0.1883948243508423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,17199,308,1.02 [0.91-1.15],0.6949115815693698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,16602,297,1.03 [0.86-1.23],0.745080094187778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,17167,307,1.14 [0.93-1.41],0.2151746020823893
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,16787,294,0.72 [0.57-0.92],0.0088194893411054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,17214,308,2.59 [1.81-3.71],2.1036027981646802e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,16725,292,1.14 [0.90-1.45],0.2716845106699926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,19666,333,1.01 [0.93-1.10],0.7391785510265723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,16664,295,2.41 [1.71-3.40],5.214693102936637e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,17101,307,2.03 [1.62-2.53],5.837690598391185e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,17167,307,0.85 [0.65-1.10],0.215875257342075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,19929,340,2.76 [1.97-3.84],2.455713724112046e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,16725,292,2.42 [1.76-3.34],6.711295672388788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,16677,295,0.80 [0.58-1.11],0.1798794662539563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,16677,295,0.82 [0.57-1.18],0.2747835634745524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,16895,301,0.94 [0.77-1.14],0.5357131986924226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,19301,331,1.02 [0.87-1.18],0.8303250702511416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,16895,301,1.09 [0.90-1.32],0.3811540322233345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,16725,292,0.94 [0.80-1.10],0.4535519027675607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,19768,339,2.29 [1.56-3.34],2.0715476621583344e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,19950,342,1.28 [0.83-1.97],0.2597480223337661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,16725,292,0.78 [0.40-1.52],0.4579424555941755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,19764,335,0.99 [0.73-1.36],0.9629109739872443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,19668,335,1.27 [1.02-1.60],0.033957626563373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,16677,295,1.04 [0.70-1.54],0.8478684784186302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,16895,301,0.99 [0.83-1.18],0.9098006475238484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,16735,300,0.92 [0.68-1.24],0.5794003822028173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,16725,292,1.12 [0.83-1.50],0.4605531005545421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,16602,297,1.00 [0.74-1.35],0.993789290677504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,16735,300,1.05 [0.96-1.14],0.310267572187014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,19301,331,1.33 [1.12-1.60],0.0014966525775677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,19301,331,1.01 [0.87-1.18],0.87016944272761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,16636,304,1.17 [1.03-1.31],0.0118607904126942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,19592,336,1.85 [1.41-2.42],6.8076246622041465e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,19939,343,1.51 [1.09-2.09],0.014422706767388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,19668,335,0.83 [0.59-1.16],0.2656170925617738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,16602,297,1.28 [1.05-1.55],0.0127156393239483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",17167,307,1.08 [0.96-1.22],0.1917744468920269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,19939,343,0.63 [0.47-0.85],0.0020413856847347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,19301,331,0.99 [0.89-1.10],0.8554155965190511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,19950,342,1.04 [0.89-1.23],0.59357131535985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,16602,297,1.06 [0.75-1.50],0.7423709335464159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,19611,331,1.35 [1.14-1.60],0.0005871230719081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,19465,330,1.21 [1.05-1.38],0.0068042056493664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,16677,295,1.06 [0.77-1.48],0.7103822289525679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,17167,307,1.36 [1.11-1.67],0.0026417028380915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,19300,328,1.25 [1.07-1.47],0.0050701990065029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,17140,308,1.12 [0.88-1.42],0.3577944053287863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,19829,337,0.91 [0.76-1.09],0.3133329208133336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,17167,307,1.33 [1.08-1.63],0.0078556965312342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,19402,328,1.08 [0.91-1.29],0.369692920626484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,17206,307,1.07 [0.76-1.51],0.6974623395480242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,17167,307,1.36 [0.94-1.97],0.1040713399080137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,16636,304,0.96 [0.77-1.21],0.744048496501702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,19752,333,0.99 [0.86-1.14],0.8703524881697293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,16895,301,0.94 [0.79-1.12],0.4965066233109177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,17140,308,0.99 [0.90-1.10],0.9219009870024104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,16602,297,1.27 [0.99-1.62],0.0568993952428954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,16602,297,0.94 [0.72-1.22],0.6239543511687882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,16895,301,0.98 [0.83-1.15],0.7766149175948901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,17167,307,1.00 [0.67-1.49],0.9805886883246936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,17170,308,1.57 [1.15-2.15],0.0048950870135706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,19668,335,1.12 [1.00-1.27],0.0532394102707099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,19950,342,1.07 [0.78-1.48],0.6606094754422964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,19332,331,1.13 [0.95-1.35],0.1762481872647682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,19213,327,1.59 [1.21-2.09],0.001024697493134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,20015,341,1.44 [1.15-1.80],0.0014443246133438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,19950,342,2.44 [1.76-3.39],9.652761101413341e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,19858,341,0.98 [0.73-1.32],0.9156342970601398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,19768,339,1.15 [0.86-1.55],0.3453460888468538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,19772,339,0.62 [0.53-0.73],2.515799861876877e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,16602,297,1.06 [0.74-1.54],0.7401336482601493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,16814,295,1.79 [1.18-2.72],0.0064448731076619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,19811,340,1.25 [1.13-1.39],2.0830197043885205e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,19413,332,0.91 [0.73-1.15],0.4446056608684623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,16636,304,0.92 [0.78-1.09],0.3517119268263271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,19888,341,1.43 [1.18-1.73],0.0002383362906715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,16636,304,1.03 [0.80-1.32],0.8455138486230168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,16735,300,1.19 [0.79-1.80],0.3948010010129531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,16735,300,1.19 [0.87-1.63],0.2732245883643278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,16636,304,0.92 [0.70-1.20],0.5322426485994427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,16725,292,0.84 [0.65-1.10],0.2157652744587501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,19301,331,1.23 [1.09-1.39],0.0009220642281047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,16665,292,1.34 [1.08-1.67],0.0089283599296512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,17199,308,1.32 [0.90-1.93],0.1583988252401632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,16725,292,1.10 [0.97-1.25],0.1256031479415561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,19752,333,1.05 [0.88-1.26],0.5934170511580772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,16735,300,0.58 [0.45-0.74],2.2781706978886096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,19764,335,1.44 [1.16-1.80],0.0011325496633895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,19764,335,0.82 [0.67-1.00],0.0502034932917668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,17140,308,1.00 [0.90-1.11],0.9939750806155212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,17141,308,1.26 [1.08-1.47],0.0041159220966019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,16814,295,1.23 [0.91-1.67],0.1705538606191096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,16725,292,0.99 [0.85-1.15],0.8575226048213263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,16725,292,1.62 [1.25-2.11],0.0002884793196096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,20015,341,1.48 [1.21-1.80],0.000132760747751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,17206,307,0.28 [0.17-0.46],4.260913030671123e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,17206,307,0.93 [0.57-1.51],0.76701536776859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,19867,338,1.17 [0.99-1.40],0.0725391094936466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,19752,333,1.60 [1.14-2.24],0.0069532143403154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,19764,335,1.32 [0.92-1.91],0.1311167347875825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,16814,295,1.00 [0.77-1.30],0.9978197408130184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,19668,335,1.11 [0.78-1.58],0.5605942728902169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,19950,342,1.18 [0.85-1.63],0.3299202308236225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,16677,295,1.26 [0.80-1.99],0.3207535118588909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,19945,340,1.11 [0.79-1.55],0.5515242585736748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,17167,307,1.32 [1.15-1.51],7.580205368591032e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,16895,301,1.05 [0.85-1.29],0.6590341737308262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,17124,306,2.13 [1.61-2.82],1.3455062138441338e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,19668,335,0.82 [0.57-1.18],0.2861775986957964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,16899,304,6.89 [2.49-19.06],0.0002012155357188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,20015,341,1.96 [1.54-2.49],5.053456875263196e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,19191,324,0.90 [0.81-1.00],0.0421715483683047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,17158,306,4.48 [2.56-7.82],1.4024669277372414e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,16912,303,0.37 [0.23-0.59],3.000768065140031e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,16966,304,0.60 [0.40-0.89],0.0111595285704416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,17206,307,3.12 [1.58-6.17],0.0010749972613704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,17206,307,1.70 [0.94-3.10],0.0817997532820495
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,19585,334,1.19 [1.04-1.35],0.0111202794990484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,19707,338,0.98 [0.88-1.10],0.7207611994398956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,19402,328,0.92 [0.74-1.14],0.4579843559404823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,19883,342,1.02 [0.86-1.21],0.8104143733375154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,20006,342,1.14 [0.99-1.32],0.0681107290308924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,19592,336,0.94 [0.69-1.30],0.7262735999757524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,17178,306,0.32 [0.15-0.68],0.0029754934457895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,17178,306,2.02 [1.36-2.99],0.0004481761984679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,20015,341,1.19 [1.02-1.39],0.0226084174259708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,17199,308,1.11 [0.93-1.31],0.2436557141358923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,16946,305,1.63 [1.06-2.50],0.0245802256671823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,16894,304,0.39 [0.17-0.93],0.0328752284926905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,17178,306,3.36 [1.84-6.12],7.523102600082829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,16895,301,1.09 [0.99-1.19],0.0648999178613529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,16787,295,1.51 [1.05-2.17],0.0248994055280707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,17141,308,0.87 [0.71-1.05],0.154703845329531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,19332,331,1.03 [0.87-1.21],0.7584990642236336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,19518,334,1.11 [0.81-1.52],0.5045839000700412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,16735,300,1.21 [0.85-1.73],0.2890093795676518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,19829,337,0.78 [0.54-1.11],0.1638881646572728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,19668,335,2.18 [1.54-3.08],1.2070826421032549e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,19668,335,1.08 [0.94-1.24],0.2618298906273111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,19522,335,1.55 [1.27-1.88],1.089459376391714e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,16814,295,0.87 [0.65-1.16],0.3457807525303411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,19301,331,1.38 [1.19-1.59],2.19873469426657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,19301,331,1.42 [1.21-1.66],1.3566687201000096e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,19764,335,1.13 [0.98-1.31],0.0916095096000289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,16934,305,1.31 [1.08-1.59],0.0070880970241983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,19301,331,1.02 [0.92-1.13],0.7175580025216747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,19752,333,1.03 [0.87-1.21],0.7427372861203172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,16636,304,0.98 [0.81-1.20],0.8735371298071332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,17141,308,0.95 [0.76-1.21],0.6986177899197794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,16795,298,0.95 [0.82-1.08],0.4201115489743875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,17155,308,1.18 [1.00-1.40],0.0503940672921271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,17214,308,1.85 [1.44-2.37],1.480782338779518e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,16595,297,1.00 [0.91-1.11],0.9621284079521824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,16574,296,0.91 [0.78-1.06],0.2173710798235839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,16677,295,0.88 [0.65-1.18],0.379051176806122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,17201,308,2.58 [1.92-3.48],4.54456538740861e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",19811,340,1.05 [0.94-1.18],0.3939078315244796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,16895,301,1.09 [0.81-1.47],0.5782919729357334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,19793,337,1.62 [1.32-1.99],5.044131965918879e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,19840,341,2.14 [1.73-2.65],2.0349124347122968e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,19752,333,1.92 [1.49-2.47],5.134286809256103e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,19332,331,1.02 [0.89-1.16],0.8079962186346293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,19776,339,1.10 [1.00-1.20],0.0581775173676613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,19939,343,1.01 [0.75-1.35],0.968061929256341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,19764,335,1.97 [1.39-2.79],0.0001414405203212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,16725,292,1.22 [0.95-1.56],0.1185778062225708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,19911,341,1.74 [1.26-2.41],0.000736910918157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,16725,292,1.17 [0.83-1.63],0.3704303235957165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,19823,339,1.22 [1.01-1.46],0.0340876563921079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,19703,337,1.48 [1.21-1.82],0.000166152367044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,16677,295,0.89 [0.75-1.06],0.2065671568430606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,19668,335,1.05 [0.94-1.19],0.3770211993200163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",19332,331,0.92 [0.75-1.13],0.4242534911300747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,19413,332,1.21 [1.01-1.44],0.0335343276913824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,19565,336,1.00 [0.87-1.15],0.9947781123192582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,19840,341,1.02 [0.92-1.12],0.7267661472822344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,16602,297,0.96 [0.70-1.30],0.7816889608099242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,17167,307,0.99 [0.89-1.10],0.7900166604068392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,19413,332,1.45 [1.22-1.72],1.929278352280436e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,19301,331,1.46 [1.14-1.86],0.002778268741774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,19752,333,1.64 [1.41-1.91],1.9150585743305343e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,19301,331,1.62 [1.33-1.96],1.100431634232891e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,16602,297,1.61 [1.07-2.43],0.0233328566960668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,17140,308,0.88 [0.70-1.10],0.2623191468008342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,19332,331,1.38 [1.19-1.61],2.457287972164322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,16735,300,1.02 [0.80-1.30],0.8964549222138184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,19332,331,1.14 [0.99-1.31],0.0638490635974012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,16595,297,1.06 [0.88-1.28],0.5513841605463463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,16595,297,0.74 [0.56-0.98],0.0325542125191452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,19332,331,1.18 [0.90-1.56],0.2343301266526518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,19752,333,0.93 [0.77-1.14],0.4883370631686244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,16735,300,1.03 [0.87-1.23],0.7069852390183449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,17201,308,0.86 [0.67-1.09],0.2130194555045664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,16602,297,1.04 [0.88-1.22],0.6482282351024795
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,16814,295,1.04 [0.91-1.19],0.5672427486776024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,17141,308,1.15 [0.93-1.43],0.1924274567172119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",16595,297,1.07 [0.88-1.30],0.503178673612865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,19332,331,1.39 [1.17-1.65],0.0001509692110174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,16677,295,0.57 [0.40-0.81],0.0017908334422604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,19939,343,0.71 [0.56-0.90],0.0042183430223813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,19402,328,0.73 [0.55-0.99],0.0400214087473134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,16895,301,0.87 [0.73-1.04],0.1346366830705417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,17141,308,1.07 [0.94-1.23],0.3221250539265007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,17085,307,1.20 [0.90-1.60],0.2167357615637015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,19301,331,0.96 [0.86-1.09],0.5514296301509786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,17140,308,1.04 [0.89-1.22],0.6058648032685501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,17140,308,0.91 [0.73-1.14],0.4210611264216211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,19668,335,1.38 [0.82-2.32],0.2225136625925589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,19332,331,1.11 [0.97-1.28],0.1393701020447058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,16595,297,0.97 [0.77-1.22],0.8124000178529592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,17141,308,1.13 [0.97-1.33],0.1181311797915591
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,19939,343,1.31 [0.97-1.76],0.073245590658584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,19840,341,1.80 [1.42-2.29],1.5364802336395529e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,19859,340,1.73 [1.45-2.05],6.477285838325531e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,16677,295,0.89 [0.69-1.15],0.3713599897292265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,19803,340,1.17 [1.01-1.36],0.0337107746263473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,17140,308,1.10 [0.96-1.26],0.1633418924730302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,16636,304,1.04 [0.86-1.26],0.7094329413777137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,17120,307,1.13 [1.01-1.28],0.0411156598093558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,19764,335,1.01 [0.89-1.13],0.9255417718287324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,16636,304,1.05 [0.84-1.32],0.6764420498687502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,19829,337,1.07 [0.96-1.19],0.2453387606609316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,17167,307,0.89 [0.73-1.08],0.2400436146828887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,16814,295,0.98 [0.89-1.08],0.671867340428774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,19592,336,1.14 [0.98-1.32],0.0943976248414856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",16725,292,1.64 [1.19-2.27],0.002769463803317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',17155,308,1.19 [0.97-1.46],0.0922501357287711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,16602,297,0.92 [0.75-1.11],0.3797058117373884
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,16814,295,1.02 [0.82-1.26],0.8723848808743919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,17141,308,1.08 [0.83-1.40],0.5716494790576385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,17140,308,1.02 [0.89-1.18],0.734349772213224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,16725,292,1.02 [0.69-1.51],0.919942521434437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,19764,335,1.07 [0.93-1.24],0.3485073937200987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],19394,327,1.18 [0.95-1.45],0.1281636122727972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",19776,339,2.07 [1.67-2.58],6.559066878129148e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,17214,308,1.09 [0.92-1.30],0.3033177441688649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,17167,307,1.45 [1.16-1.81],0.0010938781266711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,19301,331,1.44 [1.10-1.88],0.0085051788947402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,19857,339,0.99 [0.86-1.14],0.914196791171295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,19737,335,1.27 [0.99-1.64],0.0621699119177174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,19737,335,0.71 [0.55-0.92],0.0092648794170719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,16735,300,1.17 [0.94-1.45],0.1602908335367686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,17129,306,0.87 [0.53-1.43],0.5806779449890436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,16735,300,1.05 [0.68-1.62],0.8253257531581765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,17167,307,1.05 [0.70-1.57],0.8264984596904152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,17167,307,1.00 [0.82-1.22],0.9778166320099404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,19829,337,1.10 [0.95-1.27],0.2081905928788102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,19801,336,1.02 [0.71-1.46],0.9298437129302212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,16814,295,1.04 [0.89-1.20],0.6345054495812649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,17199,308,1.44 [1.04-2.00],0.0303920172977208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,19776,339,1.72 [1.41-2.10],9.350159540197465e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,16814,295,1.05 [0.77-1.43],0.7762791058734996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,19752,333,1.16 [1.00-1.34],0.0482822032326118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,19776,339,1.05 [0.79-1.39],0.7261443501155114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,19939,343,1.08 [0.90-1.31],0.3985992160457089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,16602,297,0.92 [0.67-1.26],0.61658727606845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,19703,338,3.00 [2.25-4.00],6.180637796613354e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,19840,341,1.34 [1.05-1.71],0.0189178120622257
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,17141,308,0.91 [0.85-0.97],0.0050461896764995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,19592,336,1.06 [0.72-1.56],0.7714837178565339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,19768,339,2.66 [2.04-3.46],3.108694064358828e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,19670,335,2.46 [1.90-3.19],1.0538981739529104e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,19988,341,1.58 [1.29-1.95],1.1529414925884662e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",16677,295,1.06 [0.81-1.40],0.6658598871101793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,16595,297,0.98 [0.79-1.22],0.8484521993309013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,16895,301,0.95 [0.82-1.10],0.5092822006191974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,17155,308,1.23 [1.04-1.47],0.0172787657326336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,19413,332,1.03 [0.93-1.15],0.555890252092961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",16636,304,1.12 [0.77-1.63],0.5492980414836344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,17155,308,1.14 [0.86-1.50],0.3631365429001011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,19799,336,0.97 [0.89-1.06],0.4969148468628522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,19668,335,1.14 [0.97-1.34],0.1021594944676436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,19752,333,1.01 [0.90-1.13],0.8997752624832029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,17199,308,1.74 [1.28-2.37],0.0003824510629939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,19332,331,1.04 [0.88-1.24],0.6258524512421801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",16677,295,1.05 [0.76-1.45],0.7850528884472687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,19737,335,0.67 [0.62-0.74],2.618651798506961e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,19867,338,1.19 [0.95-1.49],0.1376016663749198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,16595,297,0.70 [0.45-1.08],0.1079399596156151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,17141,308,1.24 [1.00-1.53],0.0471001749380651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,16814,295,0.94 [0.76-1.16],0.5501695109056248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",19668,335,1.30 [1.04-1.62],0.0210507086635097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20015,341,2.30 [1.74-3.04],4.199211088667666e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",16677,295,0.84 [0.63-1.13],0.2555176704168413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,17201,308,2.11 [1.41-3.15],0.0002690998428721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,17140,308,1.17 [0.88-1.55],0.2901868380544157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,19565,336,1.04 [0.88-1.22],0.6489864580692319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,16677,295,1.08 [0.93-1.26],0.3006742469131297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,19668,335,0.97 [0.91-1.05],0.5025769018151318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,16595,297,1.00 [0.83-1.22],0.9865032758287642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,19950,342,1.29 [1.05-1.58],0.0157018535237517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,19754,339,1.02 [0.69-1.53],0.9096970350034088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,16636,304,1.00 [0.85-1.17],0.9564455221037438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,19735,338,1.09 [0.93-1.27],0.296639929645461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,19402,328,1.04 [0.91-1.20],0.5774201631199137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,19332,331,0.98 [0.83-1.15],0.7746420409536788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,19764,335,1.01 [0.90-1.13],0.883400302255214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",16595,297,1.00 [0.87-1.14],0.9987088020127712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,19301,331,0.99 [0.82-1.19],0.905236945484259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,16735,300,1.03 [0.78-1.35],0.8395837934218565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,17155,308,1.12 [0.83-1.50],0.4600310477940783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,19668,335,1.13 [0.97-1.32],0.122823490065839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,16677,295,0.95 [0.70-1.28],0.7241163052815496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,19301,331,1.02 [0.87-1.20],0.7759308538525925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,16677,295,1.12 [0.87-1.43],0.3771829900727236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,19752,333,1.21 [0.99-1.47],0.0612790872962265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,17167,307,1.08 [0.93-1.25],0.3183461735127925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,19301,331,1.12 [0.89-1.40],0.3477686150167226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,17141,308,0.92 [0.69-1.22],0.5481706580808796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,19301,331,1.03 [0.91-1.18],0.6130468725238076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,19950,342,0.99 [0.92-1.07],0.8675222717350106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,19752,333,1.48 [1.30-1.69],2.0198178306464543e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,16677,295,1.09 [0.91-1.29],0.3527953313621763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,19950,342,1.13 [0.93-1.37],0.2115732920835883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",17167,307,1.11 [0.93-1.32],0.2454263905475888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,19402,328,0.98 [0.79-1.21],0.862540141653677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,19776,339,2.43 [1.85-3.20],2.503110852519341e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,17140,308,0.89 [0.67-1.20],0.4436939177397397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,16735,293,0.64 [0.46-0.89],0.0083121680249769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,16735,300,1.16 [0.97-1.39],0.0944034007662512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,17141,308,1.29 [0.96-1.74],0.0902722504502384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,16814,295,1.00 [0.82-1.22],0.9960989174168164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,16636,304,1.02 [0.84-1.25],0.8314660889055776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,17155,308,1.10 [0.82-1.47],0.5364199765393232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,17199,308,1.06 [0.91-1.24],0.4229578570093817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,16895,301,0.98 [0.88-1.10],0.7766448349359559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,19668,335,0.93 [0.85-1.01],0.0824943246299275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,17519,306,1.90 [1.37-2.65],0.0001247671158535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,17140,308,1.16 [0.88-1.52],0.3074195688439179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,19668,335,1.42 [1.10-1.83],0.0070969901441343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,16595,297,0.90 [0.73-1.10],0.2905728067947002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,17144,307,1.19 [0.93-1.52],0.1669079345405896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,19413,332,1.04 [0.90-1.21],0.5776203156260304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,16895,301,0.88 [0.71-1.09],0.2467841615613516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,19332,331,1.04 [0.91-1.18],0.5884807489871005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",16735,300,1.12 [0.97-1.29],0.1132275275282623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",17140,308,1.30 [0.97-1.76],0.0822297798257986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,17155,308,1.14 [0.96-1.37],0.1420805826983887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,19332,331,1.01 [0.80-1.28],0.9136918751444344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,19668,335,0.99 [0.89-1.11],0.8824460890985996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,19752,333,1.01 [0.89-1.15],0.8911096425781325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,16814,295,1.03 [0.90-1.18],0.6959197412212557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,19592,336,1.02 [0.92-1.13],0.6716408650027725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,19592,336,1.02 [0.90-1.16],0.7522012065432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,19301,331,0.96 [0.85-1.08],0.4635099336737422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,16735,300,0.96 [0.76-1.21],0.743078660191042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,19567,336,0.96 [0.87-1.06],0.3926911649578647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,19402,328,1.02 [0.90-1.16],0.7344756445039211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,16883,303,1.89 [1.47-2.42],4.689076830620955e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,19988,341,2.10 [1.59-2.78],1.9650447287397938e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,17199,308,1.39 [1.03-1.88],0.0305491901141414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,16895,301,1.17 [0.99-1.38],0.0649514794952319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,17199,308,2.28 [1.60-3.25],5.746349736745066e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,19332,331,1.05 [0.98-1.13],0.1399221414083116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",16735,300,1.46 [1.16-1.84],0.0013335038105853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,17140,308,1.00 [0.84-1.18],0.984918916514806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,19332,331,1.08 [0.96-1.22],0.2203695728275004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,16602,297,0.94 [0.71-1.26],0.6816643671537705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,19829,337,1.63 [1.04-2.54],0.0317306226707388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,16677,295,1.12 [0.75-1.68],0.5761584846583618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,16865,301,1.02 [0.91-1.14],0.7525665980448157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,16735,300,0.72 [0.59-0.89],0.0017649237470362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,16895,301,0.99 [0.75-1.31],0.9406744014368352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,17206,307,1.37 [0.80-2.33],0.2482386174220666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,16636,304,1.06 [0.88-1.29],0.5156737680372958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,19683,336,1.46 [1.31-1.62],3.1916978369628688e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,19811,340,2.10 [1.83-2.42],2.2903691669104878e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,19774,335,1.89 [1.56-2.29],1.3198609213298742e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,19733,336,1.29 [0.95-1.74],0.1022617010892441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,19776,335,1.58 [1.34-1.86],4.94924068059957e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,19864,335,1.11 [0.86-1.44],0.4036037142107436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,17140,308,0.87 [0.78-0.98],0.0246526269394019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,19752,333,1.99 [1.67-2.38],2.9751261958324263e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,19972,341,1.90 [1.51-2.40],5.917455320537621e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,17140,308,1.19 [0.96-1.47],0.1228207578593506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,19671,335,1.62 [1.12-2.35],0.0100690107219897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,16677,295,1.58 [0.99-2.51],0.0528274293681318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,19829,337,1.85 [1.44-2.37],1.637695186621359e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,20015,341,1.48 [1.07-2.04],0.0177404087617472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,19733,335,1.11 [0.97-1.27],0.1241016703900103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,17214,308,1.71 [1.13-2.60],0.0115996745416208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,16568,296,0.90 [0.78-1.05],0.1939574515137463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,19764,335,1.32 [0.94-1.85],0.1082098318216035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,19776,339,2.57 [2.11-3.13],8.721354001314821e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,19802,337,1.53 [1.24-1.88],6.810659724342037e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,19668,334,1.31 [0.97-1.75],0.0742196715861837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,19402,328,0.96 [0.75-1.24],0.7690324835892585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,16602,297,1.09 [0.99-1.20],0.0817558722265687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,16554,288,1.18 [0.84-1.65],0.349579687278797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,17097,307,0.96 [0.84-1.10],0.5742155274742251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,19950,342,1.43 [1.03-1.98],0.0309049912701598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,19192,322,1.02 [0.94-1.11],0.6276068106350376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,20015,341,1.43 [1.09-1.87],0.0098552592436817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",19305,331,1.30 [1.06-1.59],0.0125182195889874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,16895,301,1.16 [0.86-1.59],0.3330100990515345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,19867,338,1.50 [1.20-1.87],0.0003351639118984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,17199,308,1.14 [0.87-1.50],0.3377444047304969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,17155,308,1.03 [0.91-1.18],0.6153062115951481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,19580,332,2.81 [2.14-3.69],1.3030812963232657e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,17199,308,1.43 [1.06-1.94],0.0207993012074531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,19840,341,1.12 [1.04-1.21],0.0019047404409238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,19776,339,2.41 [1.95-2.99],9.45214320034971e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,19705,335,1.32 [0.85-2.05],0.2215739770565293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,19829,337,0.97 [0.86-1.09],0.5979768029747539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,16636,304,1.33 [1.04-1.70],0.021991486372081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",16895,301,1.17 [0.92-1.48],0.1933001105208143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,16677,295,1.37 [0.88-2.11],0.1625563539979638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,16895,301,1.53 [0.93-2.51],0.0954353149321859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,20006,342,1.07 [0.91-1.26],0.4054498382925193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,16677,295,1.65 [1.12-2.44],0.0112197045059938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,16735,300,1.14 [0.91-1.41],0.2499530848370273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,16895,301,0.89 [0.70-1.13],0.3272122791155037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,16602,297,0.93 [0.70-1.24],0.638037931684198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,16602,297,1.06 [0.86-1.31],0.572433121425286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,17141,308,1.06 [0.95-1.18],0.3129593543445301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,17140,308,0.96 [0.82-1.13],0.6360771306754769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,16725,292,1.32 [1.10-1.59],0.0024732756641783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,17167,307,1.20 [0.97-1.48],0.0891603033202454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,16595,297,0.99 [0.72-1.34],0.9274405055821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,16636,304,0.93 [0.79-1.10],0.427353676143684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,17124,306,1.87 [1.44-2.45],3.8703253523126615e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,19668,335,0.94 [0.84-1.05],0.2771512072135738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,19500,335,0.99 [0.76-1.30],0.9499236555216458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,19776,339,1.14 [1.00-1.30],0.0461782850990041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,19867,338,1.78 [1.46-2.15],6.10514539762079e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,19380,328,1.47 [1.17-1.86],0.0010395112862583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17141,308,1.28 [1.05-1.57],0.0137645505204415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,19413,332,1.07 [0.81-1.42],0.6304640175334384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,16814,295,0.97 [0.80-1.16],0.708334029595218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,19592,336,2.61 [2.06-3.31],1.5994058117915485e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,19592,336,1.61 [1.41-1.83],1.300009953103379e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,19837,339,1.43 [1.16-1.77],0.0006999655556516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20006,342,1.60 [1.27-2.00],5.483825922782254e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,19740,338,3.39 [2.54-4.53],1.6390434664745178e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,19829,337,2.07 [1.64-2.63],1.7703024177480122e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,19768,339,1.32 [1.03-1.68],0.0253981892651597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,19413,332,0.81 [0.63-1.03],0.0861175104313932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,19768,339,1.97 [1.48-2.62],3.386371766213919e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,16814,295,1.40 [1.07-1.83],0.0141830618607018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,19939,343,1.08 [0.81-1.45],0.5984743938990063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,19776,339,2.48 [1.88-3.25],7.447663846298866e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,19776,339,1.85 [1.54-2.23],4.779856405958408e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,19950,342,1.88 [1.35-2.63],0.0001890904223392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,19972,341,1.66 [1.30-2.10],3.6315951811799455e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,19592,336,1.56 [1.34-1.82],6.071606211987133e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,19950,342,1.23 [1.00-1.51],0.055379123329759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,19592,336,1.43 [1.17-1.75],0.0003822512506166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,20006,342,0.52 [0.36-0.76],0.0006401313890287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,19752,333,0.72 [0.62-0.85],8.029678570218921e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,20006,342,0.47 [0.33-0.67],2.626280725665889e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,19840,341,2.37 [1.68-3.33],7.281125693595345e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,19982,340,2.54 [1.92-3.38],1.0452050239208e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,19592,336,1.24 [1.05-1.46],0.0100156111127101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,17201,308,1.51 [1.14-2.00],0.0041196705107763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,17155,308,1.05 [0.92-1.20],0.4818196657009138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,17201,308,0.84 [0.64-1.09],0.1879799407111763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",19402,328,1.06 [0.93-1.20],0.3818824776732745
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,16895,301,1.10 [0.78-1.55],0.5800592790588652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,19592,336,0.55 [0.43-0.70],5.973745643674218e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,19776,339,1.44 [0.99-2.10],0.0551998749855109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17199,308,1.16 [1.01-1.34],0.0373521303112183
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,17141,308,1.06 [0.96-1.16],0.2749161884284055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",16595,297,1.02 [0.79-1.30],0.9048441528332754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,16677,295,1.09 [0.94-1.25],0.2548244324502269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,16725,292,1.00 [0.81-1.24],0.9955968353971436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,19301,331,0.87 [0.68-1.11],0.2592134127667173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,16677,295,1.10 [0.96-1.27],0.1588451191632595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,16452,291,1.28 [1.04-1.59],0.0218342203821678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,19402,328,1.20 [0.89-1.63],0.2342450076584473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,16735,300,0.95 [0.68-1.35],0.7896232157164267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,16735,300,1.11 [0.84-1.46],0.4832054880748467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,16814,295,0.98 [0.88-1.10],0.7745546083542602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,17199,308,1.31 [0.89-1.91],0.1678766403064404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,16602,297,1.03 [0.79-1.33],0.8487064770720674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,19301,331,1.07 [0.93-1.23],0.3360585852359832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,19608,336,1.89 [1.60-2.24],1.974464865121145e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,16895,301,1.04 [0.89-1.21],0.6060984179244546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,19332,331,0.98 [0.75-1.29],0.9104168408267148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,16602,297,1.10 [0.90-1.36],0.3454114027874622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,16595,297,0.98 [0.81-1.18],0.7991138975206364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,19974,342,0.88 [0.72-1.06],0.1749829289970188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,17167,307,0.94 [0.68-1.29],0.6925296440688447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,16677,295,0.93 [0.59-1.47],0.7595042817082437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,19413,332,0.84 [0.69-1.01],0.0663594526761283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,19752,333,0.88 [0.76-1.02],0.1014602114238166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",16677,295,0.77 [0.55-1.08],0.1304531346542763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,16602,297,0.88 [0.68-1.15],0.3446859430304889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,16895,301,1.13 [1.00-1.28],0.0533828893779327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,17201,308,0.77 [0.67-0.90],0.0006621053571157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,19740,338,1.81 [1.53-2.14],4.421378895568193e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,17214,308,1.03 [0.84-1.27],0.7707645786203653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,19776,339,0.72 [0.54-0.97],0.0278019878719187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,19939,343,1.24 [1.06-1.44],0.0076134101600156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,19752,333,0.93 [0.81-1.06],0.275444599465838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,16867,300,1.01 [0.85-1.20],0.9159847408506804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,17141,308,1.03 [0.92-1.14],0.6040399476575012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,16595,297,1.03 [0.85-1.26],0.7364072511945726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,16735,300,1.00 [0.86-1.17],0.9583871164662618
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,19752,333,0.94 [0.84-1.06],0.3220788821356323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,17140,308,1.01 [0.88-1.16],0.8679506635700678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,16602,297,0.97 [0.76-1.25],0.8305427057512154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,16677,295,0.84 [0.69-1.03],0.0901801288466907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,17167,307,1.10 [0.92-1.31],0.2899612697151191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,19764,335,0.95 [0.83-1.09],0.4758421976784792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,19402,328,1.12 [0.97-1.31],0.1290607436485904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,16602,297,1.00 [0.74-1.35],0.9978193851372452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,19402,328,0.71 [0.58-0.86],0.0005076828211313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,16602,297,0.94 [0.73-1.22],0.6416234287280058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,16636,304,0.92 [0.80-1.06],0.2463879205349718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,17141,308,1.35 [1.20-1.51],3.215518763432552e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,16677,295,1.12 [0.84-1.50],0.4483571210160965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,19297,331,1.09 [0.95-1.24],0.2091296207513886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,16735,300,1.06 [0.84-1.34],0.6245815300394614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,16602,297,1.01 [0.83-1.22],0.9507663206778804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,17033,304,0.29 [0.20-0.43],1.1067881305604051e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,16636,304,1.45 [0.98-2.15],0.0647332277888767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,17201,308,1.06 [0.93-1.21],0.3755724651327782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,16895,301,0.91 [0.76-1.08],0.2769702527451225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,19592,336,1.06 [0.94-1.19],0.3381065204673364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,16939,301,1.17 [0.91-1.50],0.2170898284762412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,19829,337,2.55 [1.84-3.54],1.93944570160858e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,19950,342,1.25 [1.09-1.44],0.0014003658128027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,17155,308,1.15 [0.94-1.42],0.1790491432517535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,16605,303,1.00 [0.88-1.14],0.9802607187665242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",19776,339,1.16 [0.94-1.43],0.1777452590885017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,19639,330,1.20 [1.03-1.40],0.0192575965542062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,19764,335,1.51 [1.06-2.15],0.0230027625707964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",16677,295,0.98 [0.81-1.18],0.7954563435479767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,19668,335,0.99 [0.73-1.34],0.9549473172059332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,17140,308,1.17 [0.77-1.79],0.4586857017683513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,17199,308,1.20 [1.00-1.44],0.0519275272435664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,16677,295,0.90 [0.72-1.13],0.3674562566663577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,16602,297,1.07 [0.86-1.32],0.5485101331863489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,16814,295,0.99 [0.84-1.17],0.9261570192072112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,17141,308,0.99 [0.91-1.07],0.7834120111093487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,16602,297,1.09 [0.97-1.22],0.1683697205455203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,16602,297,1.04 [0.73-1.48],0.8278978012415776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,19592,336,1.77 [1.40-2.24],1.5189211858950875e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,19945,340,0.77 [0.65-0.92],0.0033644524746339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,16677,295,0.73 [0.46-1.16],0.1847558764750476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,16595,297,1.00 [0.80-1.24],0.997796155541578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,17140,308,1.02 [0.72-1.42],0.9275742888718534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,17199,308,1.03 [0.92-1.17],0.5817874807782282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,16636,304,1.14 [0.90-1.45],0.2636512639130671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,16857,300,1.02 [0.83-1.25],0.8714368680274708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,16814,295,0.93 [0.78-1.11],0.4039200316161676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,16735,300,0.95 [0.79-1.15],0.6061560731503471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,19668,335,1.02 [0.91-1.14],0.7411221811352713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,17140,308,1.05 [0.90-1.24],0.5144477750793048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,17155,308,1.30 [0.99-1.71],0.0576409929563515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,16602,297,1.06 [0.92-1.21],0.4212604043914681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,19402,328,0.96 [0.86-1.07],0.5002067430512767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,19301,331,1.10 [0.91-1.34],0.3324088343455507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,19402,328,1.47 [1.27-1.71],2.222909523754701e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,16677,295,1.11 [0.97-1.27],0.1226201889308914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,19752,333,1.00 [0.89-1.13],0.9983339160437656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,19470,331,0.73 [0.50-1.05],0.0918955815365801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,17214,308,1.04 [0.89-1.21],0.6475663074259117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,19668,335,0.61 [0.36-1.02],0.0606709031185305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,16636,304,0.98 [0.87-1.10],0.7085936262600607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,19837,338,2.02 [1.46-2.81],2.721624023567891e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,19950,342,1.73 [1.26-2.36],0.0006084467111634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,16595,297,1.07 [0.93-1.22],0.3526779477123012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,19942,342,1.44 [1.23-1.68],7.240875639342036e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,16677,295,2.94 [2.00-4.32],3.687983121177333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,19829,337,1.08 [0.90-1.29],0.4163048595496947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,19978,342,1.62 [1.25-2.09],0.0002283893386063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,17167,307,0.76 [0.53-1.11],0.1555562132854231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,19402,328,1.05 [0.96-1.15],0.3067645999526984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,16725,292,1.15 [0.70-1.90],0.5761049919009738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,17199,308,1.35 [1.01-1.82],0.0441421290651703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,19668,335,1.11 [0.95-1.29],0.1762295677602369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,17214,308,1.26 [1.07-1.49],0.0067721049412128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,19668,335,2.09 [1.66-2.64],5.605128472163312e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,16895,301,0.94 [0.79-1.12],0.5130908353363711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,19668,335,0.88 [0.77-1.00],0.0559825661952516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,17140,308,0.98 [0.87-1.10],0.7048350953992599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,19668,335,1.03 [0.90-1.17],0.7041143650237346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,17140,308,1.17 [0.87-1.58],0.2910392257615017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,16602,297,1.33 [0.96-1.84],0.0896010787241321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,17140,308,1.84 [1.58-2.13],9.098720048103286e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,19754,339,1.94 [1.57-2.41],1.4378275055453975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,19735,334,1.20 [1.03-1.40],0.0207395811553728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,17155,308,1.13 [0.86-1.49],0.3696228031431574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,19332,331,1.31 [1.07-1.59],0.0084256240557693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,16895,301,1.06 [0.80-1.41],0.6859480714496603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,19402,328,1.04 [0.87-1.25],0.6376413724848042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,19950,342,1.12 [0.97-1.29],0.1249370073413417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,19301,331,1.82 [1.35-2.46],9.953691375760668e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,16814,295,1.12 [0.92-1.36],0.2742145668878158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,19916,343,2.09 [1.69-2.58],1.2424660402322847e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,16595,297,1.09 [0.96-1.25],0.176716748178769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,19529,336,1.13 [0.89-1.44],0.3163378234460439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,17167,307,0.99 [0.75-1.29],0.9192708030544696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,20015,341,1.28 [1.12-1.46],0.0002600515499158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",19776,339,1.58 [1.22-2.06],0.000638669375575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,19413,332,1.07 [0.92-1.25],0.3885763650401026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,19402,328,0.98 [0.88-1.10],0.7461174982352066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,19332,331,1.01 [0.89-1.14],0.884794522808935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,17155,308,1.03 [0.89-1.20],0.6589039396112911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,16677,295,1.05 [0.86-1.29],0.6098152910611976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,17140,308,1.08 [0.80-1.46],0.6097593873846532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,16789,301,1.12 [0.90-1.38],0.3093393791682642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,19900,343,1.28 [1.10-1.49],0.001399663522289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,18815,314,2.27 [1.88-2.74],1.2012158397842076e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",19518,334,0.30 [0.24-0.39],1.5259217914943365e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",19768,339,1.13 [0.84-1.53],0.4157982254126013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,19939,343,1.63 [1.24-2.14],0.0005086911346991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,19413,332,1.80 [1.32-2.47],0.000222240536123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,19592,336,0.92 [0.76-1.12],0.403249771299442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,19939,343,1.28 [1.08-1.51],0.0037927174366639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,19922,340,1.01 [0.76-1.34],0.959752957043983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,16677,295,1.07 [0.87-1.31],0.5275972864180444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,19829,337,1.00 [0.91-1.10],0.9435723533108732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,19332,331,1.23 [0.94-1.61],0.1374805466507736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,17155,308,2.23 [1.61-3.09],1.4123850651531588e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",17141,308,1.05 [0.97-1.14],0.2241268269872368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,19668,335,1.03 [0.94-1.13],0.477363282631819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,17140,308,0.99 [0.70-1.39],0.9331514587996814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,16602,297,0.93 [0.77-1.13],0.4849237267833362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,19413,332,1.04 [0.92-1.17],0.5522891351002222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,16814,295,1.01 [0.86-1.18],0.9257819758834726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,16677,295,0.78 [0.51-1.20],0.2620866122363854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,16677,295,0.86 [0.63-1.18],0.3479321966290977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,19301,331,0.92 [0.79-1.06],0.2391165301600617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,19402,328,1.37 [1.13-1.66],0.0016215767435989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,16602,297,1.00 [0.82-1.22],0.981883919694274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,17141,308,1.01 [0.89-1.14],0.922253862964963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,17155,308,1.08 [0.78-1.49],0.6452158069616925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,16677,295,0.93 [0.65-1.33],0.685031912906666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,16895,301,1.06 [0.89-1.25],0.5273960860441935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,17140,308,0.98 [0.84-1.14],0.7939716235144689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,17141,308,1.08 [0.92-1.27],0.3357994274449778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,17140,308,0.92 [0.74-1.14],0.4303614036846417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,16725,292,0.99 [0.95-1.03],0.625016702658687
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,16595,297,0.94 [0.65-1.37],0.7585721203347623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,16636,304,1.06 [0.94-1.19],0.3404634483860361
